Notes to the Consolidated Financial Statements
1. Accounting policies
1.01 – General information
Clariant Ltd (the »Company«) and its consolidated subsidiaries (together the »Group«) are a global leader in the field of specialty chemicals. The Group develops, manufactures, distributes, and sells a broad range of specialty chemicals, which play a key role in its customers’ manufacturing and treatment processes or add value to their end products. The Group has manufacturing plants around the world and sells mainly in countries within Europe, the Americas, and Asia.
Clariant Ltd is a limited liability company incorporated and domiciled in Switzerland. The address of its registered office is Rothausstrasse 61, CH-4132 Muttenz, Switzerland. The Company is listed on the SIX Swiss Exchange.
The Board of Directors approved the consolidated financial statements for issue on 1 March 2023. They will be subject to approval by the Annual General Meeting of Shareholders scheduled for 4 April 2023.
1.02 – Basis of preparation
The consolidated financial statements of the Clariant Group have been prepared in accordance with the International Financial Reporting Standards (IFRSIFRSThe International Financial Reporting Standards (IFRS) are international accounting standards.) and the IFRIC interpretations applicable to companies reporting under IFRSIFRSThe International Financial Reporting Standards (IFRS) are international accounting standards., and with the significant accounting policies set out below.
The consolidated financial statements have been prepared under the historical cost convention as modified by the revaluation of certain financial assets and liabilities (including derivative instruments) at fair value through profit or loss and other comprehensive income.
The preparation of financial statements in conformity with IFRSIFRSThe International Financial Reporting Standards (IFRS) are international accounting standards. requires the use of certain critical accounting estimates. It also requires Management to exercise its judgment in the process of applying the Group’s accounting policies.
These estimates and judgments affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period.
Although these are based on Management’s best knowledge of current events and circumstances, actual outcomes may ultimately differ from those estimates. The areas involving a higher degree of judgment or complexity, or areas where estimates are significant to the consolidated financial statements, are disclosed under note 4.
1.03 – Disclosure of business units as discontinued operations and disclosure of assets and liabilities as assets held for sale in accordance with IFRS 5, Non-current Assets held for sale and Discontinued operations
Following the decision of the Board of Directors to dispose of the Business Unit PigmentsPigmentsPigments are substances used for coloring; they are used in a technical manner, for example in the manufacture of dyes, varnishes, and plastics. In 2020, Clariant launched the divestment process of its Pigments business, which was completed on 3 January 2022. in June 2019, it was reclassified to discontinued operations in 2019 and is therefore presented separately in accordance with IFRSIFRSThe International Financial Reporting Standards (IFRS) are international accounting standards. 5. Assets and liabilities pertaining to the PigmentsPigmentsPigments are substances used for coloring; they are used in a technical manner, for example in the manufacture of dyes, varnishes, and plastics. In 2020, Clariant launched the divestment process of its Pigments business, which was completed on 3 January 2022. discontinued operations are presented as »assets held for sale« and as »liabilities directly associated with assets held for sale« in the balance sheet of 2021 as required by IFRSIFRSThe International Financial Reporting Standards (IFRS) are international accounting standards. 5.
The Business Unit PigmentsPigmentsPigments are substances used for coloring; they are used in a technical manner, for example in the manufacture of dyes, varnishes, and plastics. In 2020, Clariant launched the divestment process of its Pigments business, which was completed on 3 January 2022. was sold on 3 January 2022. See also note 25.
On 31 August 2022, Clariant and Global Amines Company Pte Ltd, a 50/50 joint venture owned by Clariant and Wilmar, signed an agreement to divest Clariant’s Quats business to Global Amines. The closing of the transaction is expected in the first half of 2023. As a consequence, the assets and liabilities of Clariant’s Quats business (part of Business AreaBusiness AreaFor the financial reporting, Clariant grouped its businesses in three core Business Areas: Care Chemicals, Catalysis, and Natural Resources. As of 1 January 2023, the Group conducts its business through the three newly formed Business Units Care Chemicals, Catalysts, and Adsorbents & Additives and will report accordingly as of the first quarter of 2023. Care Chemicals) were reclassified to «assets held for sale» and «liabilities directly attributed to assets held for sale» in the balance sheet of 31 December 2022. See also note 25.
On 14 April 2022, Clariant completed the sale of its 50 % stake in the joint venture, which owns Scientific Design Company. This investment was reported as «Assets held for sale» in 2021. See also note 25.
On 27 October 2022, Clariant and Dorf Ketal entered into an agreement for Dorf Ketal to acquire Clariant’s North American Land Oil business. The transaction is expected to be closed during the first half of 2023. Therefore, the assets and liabilities pertaining to that business were presented separately in accordance with IFRSIFRSThe International Financial Reporting Standards (IFRS) are international accounting standards. 5 as «assets held for sale» and «liabilities directly attributed to assets held for sale» in the 2022 balance sheet. See also note 25.
1.04 – Standards, interpretations, and amendments effective in 2022
The Group has applied the following amendments to IFRSIFRSThe International Financial Reporting Standards (IFRS) are international accounting standards. issued in 2022 by the International Accounting Standards Board (IASB):
- Amendments to IFRSIFRSThe International Financial Reporting Standards (IFRS) are international accounting standards. 3 Reference to the Conceptual Framework;
- Amendments to IAS 16 Property, Plant and Equipment – Proceeds before Intended Use;
- Amendments to IAS 37 Onerous Contracts – Costs of Fulfilling a Contract;
- Annual Improvements to IFRSIFRSThe International Financial Reporting Standards (IFRS) are international accounting standards. Accounting Standards 2018-2020 Cycle.
The adoption of the amendments did not have any significant impact on the amounts recognized in the reporting period or prior periods and are not expected to significantly affect future periods.
1.05 – Standards, interpretations, and amendments not yet effective
Certain new and amended accounting standards and interpretations that have been published are not mandatory for the reporting period ended on 31 December 2022 and have not been adopted early by the Group. These standards and interpretations are not expected to have a material impact on the entity in the current or future reporting periods or on foreseeable future transactions.
1.06 – Scope of consolidation
- Subsidiaries: Subsidiaries are those entities over which the Group has control. This is the case when it is exposed to, or has rights to, variable returns from its involvement with the entity and has the ability to affect those returns through its power over the entity. Subsidiaries are fully consolidated from the date on which control is transferred to the Group, and they are deconsolidated from the date control ceases.
- Associates: Associates are entities over which the Group has significant influence but not control, generally accompanying a shareholding of between 20 % and 50 % of the voting rights. Investments in associates are accounted for using the equity method.
- Joint arrangements: The Group applies IFRSIFRSThe International Financial Reporting Standards (IFRS) are international accounting standards. 11, Joint Arrangements. Investments in joint arrangements. are classified as either joint operations or joint ventures, depending on the contractual rights and obligations of each investor. Clariant has assessed the nature of its joint arrangements and determined them to be joint ventures. Joint ventures are accounted for using the equity method.
All associates and joint ventures apply the same accounting principles as the Group.
1.07 – Principles and methods of consolidation
The annual closing date of the individual financial statements is 31 December. The consolidated financial statements are prepared applying uniform presentation and valuation principles. The results of non-controlling interests are separately disclosed in the income statement and in the balance sheet.
1.08 – Recognition of revenue from contracts with customers
Sales of goods and services are recognized in line with the requirements of IFRSIFRSThe International Financial Reporting Standards (IFRS) are international accounting standards. 15, Revenue from Contracts with Customers. Revenue is measured based on the consideration the Group expects to receive in exchange for goods or services. Revenue from sales of goods is recognized in the income statement when control has been transferred to the buyer, which is usually upon delivery, at a fixed or determinable price, and when collectability is reasonably assured. Delivery is defined based on the terms of the sale contract. Revenue from services is recognized when the respective services have been rendered. Revenue is reported net of sales taxes, returns, discounts, and rebates. Rebates to customers are provided for in the same period that the related sales are recorded based on the contract terms.
Where third parties hold Clariant inventories on a consignment basis, revenue is recognized in the period when inventories are withdrawn from consignment and delivered to customers. Clariant periodically enters into prepayment contracts with customers whereby it receives contract liabilities for products to be delivered in a future period. These contract liabilities are recorded as liabilities and presented as part of other liabilities. Advance payment liabilities are released, and revenue associated with such advance payment transactions are recognized upon delivery and transfer of title, ownership, and risk of loss of the related products to the customer.
1.09 – Recognition of revenue from interest and dividends
Interest income is recognized on a time proportion basis, taking into account the principal outstanding and the effective rate over the period to maturity, when it is determined that such income will accrue to the Group. Dividends are recognized when the right to receive the payment is established.
1.10 – Exchange rate differences
Exchange rate differences are recognized in line with the requirements of IAS 21, The Effect of Changes in Foreign Exchange Rates. The consolidated financial statements are presented in Swiss francs, which is the functional and presentation currency of the parent company.
Transactions and balances: Foreign currency transactions are translated into the functional currency using the exchange rates prevailing on the dates of the transactions.
Foreign exchange gains and losses resulting from the settlement of such transactions and from the translation of monetary assets and liabilities denominated in foreign currencies are recognized in the line «Finance costs» in the income statement, except when deferred in other comprehensive income as qualifying cash flow hedges and net investment hedges.
Translation differences on debt securities and on other monetary financial assets measured at fair value are included in foreign exchange gains and losses in the line «Finance costs» in the income statement.
Group companies: Income statements and cash flow statements of foreign entities are translated into the Group’s presentation currency at sales-weighted average exchange rates for the year, and their balance sheets are translated at the exchange rates prevailing on 31 December.
All resulting exchange rate differences are recognized in other comprehensive income in the line «Currency translation differences». Exchange rate differences arising from the translation of the net investment in foreign entities and from borrowings and other currency instruments designated as hedges of such investments are recognized in other comprehensive income in the line net investment hedge. Net investments also include loans for which the settlement is neither planned nor likely to occur in the foreseeable future.
When a foreign operation is disposed of and as a consequence control, significant influence or joint control is lost, the cumulative amount in the translation reserve related to that foreign operation is reclassified to profit or loss as a part of the gain or loss on disposal.
When the Group holds an interest in a subsidiary that includes translation differences on a foreign operation, while retaining control of the subsidiary, a proportionate part of the cumulative amount of the translation difference that was recognized in other comprehensive income is reclassified to non-controlling interests.
1.11 – Property, plant, and equipment
Property, plant, and equipment, except for those ones pertaining to mining activities, are valued at historical acquisition or production costs and depreciated on a straight-line basis to the income statement, using the following estimated useful lives in accordance with the Group guidelines:
- Buildings 15 to 40 years
- Machinery and equipment 10 to 16 years
- Furniture, vehicles, computer hardware 3 to 13 years
- Land is not depreciated
Property, plant, and equipment pertaining to mining activities are valued at historical costs and depreciated over their useful lives to the income statement using the units of production method.
When the entity has a present legal or constructive obligation to dismantle an item of property, plant and equipment or restore a site, its initial costs include an estimate of the costs of dismantling and removing the item and restoring the site on which it is located. A corresponding provision is recorded for the amount of the asset component.
Financing costs directly associated with the acquisition, construction, or production of qualifying property, plant, and equipment are capitalized as a part of the costs of these assets. Investment property is valued at cost less depreciation. As all investment property held by Clariant consists of industrial and administrative sites that have been in use for several decades, there is no active market that would give information on possible market prices. The fair values of the investment properties are therefore determined by way of external appraisals and value-in-use calculations.
1.12 – Leases
Clariant accounts for lease contracts in accordance with IFRSIFRSThe International Financial Reporting Standards (IFRS) are international accounting standards. 16, Leases.
At the inception of the lease, a right-of-use asset and a lease liability are recognized in the balance sheet. The asset is initially measured at the amount of the lease liability plus any initial direct costs incurred. The lease liability is initially measured at the present value of the lease payments payable over the lease term, including variable lease payments based on an index at the commencement day and the exercise price of purchase options if it is reasonably certain that the option will be exercised. The lease liability is discounted at the rate implicit in the lease. If that rate cannot readily be determined, the incremental borrowing rate is used. Lease liabilities are subsequently re-measured to reflect possible changes in the lease terms.
Right-of-use assets are depreciated over the duration of the lease contract, including contractually agreed upon optional extension periods whose exercise is deemed to be reasonably certain. The depreciation is recognized in operating income.
The unwinding of the discounting effect is included in the financial expense. Lease payments are accounted for as a repayment of the lease liability.
Expenses for lease contracts for objects with a value of less than CHF 5 000 and lease contracts with a duration of up to twelve months are recognized directly in the income statement.
1.13 – Intangible assets
Goodwill is recognized in accordance with the requirements of IFRSIFRSThe International Financial Reporting Standards (IFRS) are international accounting standards. 3, Business Combinations, and IAS 38, Intangible Assets. Goodwill is not amortized but tested annually for impairment as required by IAS 36, Impairment of Assets.
Trademarks and licenses are capitalized at historical costs and amortized on a straight-line basis to the income statement over their estimated useful lives, with a maximum of ten years.
Acquired computer software licenses are capitalized on the basis of the costs incurred to acquire and bring to use the specific software. They are amortized on a straight-line basis to the income statement over their estimated useful lives (three to five years).
Costs directly associated with the production of identifiable and unique software and other intangible products controlled by the Group that will probably generate economic benefits beyond one year are recognized as intangible assets and depreciated over their useful life of three years. Direct costs include software development costs, personnel costs, and advisory costs directly related to the software or product development and an appropriate portion of the relevant overheads. Costs associated with developing and maintaining common software programs are recognized as an expense when incurred.
Intangibles acquired in a business combination, with the exception of mining rights, are amortized using a straight-line method over their remaining useful lives as follows:
- Technology 3 to 15 years
- Customer relationships 6 to 20 years
- Tradenames 10 years
- Order backlog 2 years
Mining rights are depreciated over their useful lives using the units of production method.
REACH costs were capitalized until the end of 2020 and depreciated over a period of 12 years. As of 2021, REACH costs are expensed as incurred.
1.14 – Impairment of assets
Assets that are subject to amortization and depreciation are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. If any such indication exists, the recoverable amount of the asset is estimated to determine the extent of the impairment loss (if any). Goodwill, intangible assets with an indefinite useful life and intangible assets not yet available for use are tested for impairment annually. Recoverable amount is the higher of fair value less costs of disposal and value in use.
In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.
If the recoverable amount of an asset is estimated to be less than its carrying amount, the carrying amount of the asset is reduced to its recoverable amount and an impairment loss is recognised immediately in income statement (see also note 5).
1.15 – Non-current assets and disposal groups held for sale
Non-current assets and disposal groups are classified as held for sale when their carrying amount is to be recovered through a sale transaction and a sale is considered highly probable. They are stated at the lower of the carrying amount and fair value less costs of disposal, in accordance with the requirements of IFRSIFRSThe International Financial Reporting Standards (IFRS) are international accounting standards. 5, Non-current Assets Held for Sale and Discontinued Operations.
1.16 – Inventories
Purchased goods are valued at acquisition costs, while self-manufactured products are valued at manufacturing costs, including related production overhead costs. Inventory held at the balance sheet date is primarily valued at standard costs, which approximate actual costs on a weighted-average basis. This valuation method is also used for valuing the costs of goods sold in the income statement. Adjustments are made for inventories with a lower net realizable value. Unsalable inventories are fully written off. These adjustments are recorded as valuation allowances, which are deducted directly from the inventory value in the balance sheet. The allowances are reversed when the inventories concerned are either sold or destroyed and, as a consequence, removed from the balance sheet.
1.17 – Trade receivables
Trade receivables are amounts due from customers for goods sold or services rendered in the ordinary course of business and are recognized in accordance with IFRSIFRSThe International Financial Reporting Standards (IFRS) are international accounting standards. 9, Financial Instruments. They are generally due within 40 days and therefore classified as current. Trade receivables are recognized initially at the amount of consideration that is unconditional. The Group holds trade receivables with the objective to collect the contractual cash flows and therefore measures them subsequently at amortized cost. Details about the Group’s impairment policies and the calculation of the loss allowance are provided in note 12.
The Group applies the IFRSIFRSThe International Financial Reporting Standards (IFRS) are international accounting standards. 9 simplified approach to measure expected credit losses, which uses a lifetime expected loss allowance for all trade receivables within stage 1 and 2. The estimated expected loss rates are based on historical credit losses and are adjusted to reflect current and forward-looking information on macroeconomic factors affecting the ability of the customers to settle the receivables. The Group recognizes impairment of trade receivables in »Selling, general, and administrative costs« in the income statement.
1.18 – Cash and cash equivalents, short-term deposits
Cash and cash equivalents comprise cash in hand, deposits, and calls with banks, as well as short-term investment instruments with an initial lifetime of 90 days or less. Bank overdrafts are reported within financial debt in current liabilities in the balance sheet.
Short-term deposits are disclosed separately in the balance sheet if they have an original maturity between 90 and 365 days. They are valued at their nominal value, which is close to their fair market value.
1.19 – Derivative financial instruments and hedging
Derivative financial instruments and hedges are recognized in accordance with IFRSIFRSThe International Financial Reporting Standards (IFRS) are international accounting standards. 9, Financial Instruments.
Qualifying hedge instruments are derivatives and non-derivative financial assets and liabilities that are fully measured at fair value through profit or loss. Hedged items are assets or liabilities, unrecognized firm commitments, forecast transactions or net investments in foreign entities. They are reliably measurable and, if not recognized, they are highly probable. The hedges are accounted for either as fair value hedges in the case of exposures in fair value of recognized assets and liabilities or unrecognized firm commitments, as cash flow hedges in the case of exposures in cash flows arising from recognized assets or liabilities or forecast transactions that could affect profit or loss, or as hedges of a net investment in a foreign entity.
1.20 – Current income tax
The taxable profits (losses) of Group companies are calculated in accordance with the rules established by the taxation authorities of the countries in which they operate. They are the basis for determining income tax payments (reimbursements) for the reporting period in accordance with the prevailing local income tax rates. Current income tax is accounted for in accordance with the requirements of IAS 12, Income Taxes.
1.21 – Deferred income tax
Deferred income tax is calculated using the comprehensive liability method in accordance with the requirements of IAS 12, Income Taxes. No deferred income tax is calculated for the temporary differences on investments in Group companies, provided that the investor (parent company) is able to control the timing of the reversal of the temporary differences and it is probable that the temporary differences will not reverse in the foreseeable future. Deferred income tax assets are recognized on tax losses incurred if, based on the business plans of the respective subsidiaries, it is deemed probable that the tax losses are recoverable in the foreseeable future. The recoverability of these tax losses is assessed by Management on a regular basis.
1.22 – Employee benefits
Group companies operate various post-employment schemes, including both defined-benefit and defined-contribution pension plans, post-employment healthcare plans, and other benefits. Obligations for employee benefits are determined and recorded in line with the requirements of IAS 19, Employee Benefits.
Defined-contribution plans: Contributions to defined-contribution plans are recorded in the income statement in the period to which they relate.
Defined-benefit plans: For defined-benefit plans, the amount to be recognized in the provision is determined using the Projected Unit Credit method. Independent actuaries perform the actuarial valuations for the defined-benefit plans on a regular basis. For the larger plans, these valuations take place annually. For the smaller ones, valuations are performed at least every three years, with systematic rollforwards in the years in between.
The retirement benefit obligations recognized in the balance sheet represent the present value of the obligations at the end of the reporting period less the fair value of the plan assets.
The prepaid pension assets recognized in the balance sheet are capitalized only to the extent of their recoverability, that is, when a cash refund or a reduction in the future payments is available. The return on plan assets, except for amounts reflected in net interest income, are reported under other comprehensive income.
Actuarial gains and losses are charged or credited to equity in other comprehensive income in the period in which they arise. Past service costs are recognized immediately in the income statement.
Some Group companies provide post-employment healthcare benefits to their retirees. The entitlement to these benefits is usually conditional on the employee remaining in service up to retirement age and the completion of a minimum service period. The expected costs of these benefits are accrued over the period of employment using an accounting method similar to that for the defined-benefit pension plans. Actuarial gains and losses arising from experience adjustments and changes in actuarial assumptions are charged or credited to equity in other comprehensive income in the period in which they arise.
The charges for defined-benefit plans, defined-contribution plans, and termination benefits are included in personnel expenses and reported in the income statement under the corresponding functions of the related employees.
Other long-term employee benefits are employee benefits (other than post-employment benefits and termination benefits) that do not fall wholly due within twelve months after the end of the period in which the employees render the related service.
These include long-term compensated absences, such as long-service or sabbatical leave, and jubilee or other long-service benefits. The accounting policy for other long-term employee benefits is equal to that for post-employment benefits, with the exception that actuarial gains and losses are recognized immediately in the income statement.
Short-term employee benefits are employee benefits (other than termination benefits) that fall due wholly within twelve months after the end of the period in which the employees render the related service.
1.24 – Research and development
Considering the uncertainties inherent in the development of new key products, Clariant does not capitalize the associated development costs as the criteria set up by IAS 38 Intangible Assets for capitalization are not met. Experience has proven that the structure of research and development in the industries that Clariant engages in makes it difficult to demonstrate how single intangible assets (patents) will generate probable future economic benefits.
Laboratory buildings and equipment included in property, plant, and equipment are depreciated over their estimated useful lives in accordance with the Group guidelines of note 1.11.
1.25 – Segment reporting
Segment information is presented in the same manner as in the internal reporting to the chief operating decision-maker. The chief operating decision-maker, responsible for strategic decisions, for the assessment of the segments’ performance, and for the allocation of resources to the segments, is the Executive Leadership TeamExecutive Leadership TeamThe Executive Leadership Team (ELT) consists of the Executive Steering Committee (ESC) along with the Chief Human Resources Officer, the Chief Technology & Sustainability Officer, the Chief Corporate Development Officer, and the General Counsel. By bringing all key functions together, Clariant ensures fast decision-making while incorporating all internal stakeholders’ needs. The ELT supports the ESC by promoting dialogue among its members, exchange of information and enabling awareness of the Group’s environment..
After the sale of the Business Unit MasterbatchesMasterbatchesThese are plastic additives in the form of granules with dyestuffs or other additives used to dye or alter the properties of natural plastic. in 2020, Clariant had six business units (BUs). These included the Business Unit PigmentsPigmentsPigments are substances used for coloring; they are used in a technical manner, for example in the manufacture of dyes, varnishes, and plastics. In 2020, Clariant launched the divestment process of its Pigments business, which was completed on 3 January 2022., which was reclassified to Discontinued Operations on 30 June 2019 and sold on 3 January 2022.
For external reporting purposes, the remaining five business units are grouped into three business areas (BA) (reportable segments), in accordance with IFRSIFRSThe International Financial Reporting Standards (IFRS) are international accounting standards. 8, Operating Segments:
- Care Chemicals (BU ICS)
- Catalysis (BU Catalysts)
- Natural Resources (BU Oil & Mining Services, BU Functional Minerals, BU Additives)
These five business units were grouped into business areas in such a way that they reflect, in Management’s opinion, the similar economic characteristics of certain BU’s and common traits regarding products, markets, technologies and cyclicality. These business areas have full responsibility for their operating results.
The Business AreaBusiness AreaFor the financial reporting, Clariant grouped its businesses in three core Business Areas: Care Chemicals, Catalysis, and Natural Resources. As of 1 January 2023, the Group conducts its business through the three newly formed Business Units Care Chemicals, Catalysts, and Adsorbents & Additives and will report accordingly as of the first quarter of 2023. Care Chemicals comprises the BU Industrial & Consumer Specialties (ICS), Food Additives, as well as the future Industrial Biotechnology business. It demonstrates a clear focus on highly attractive, high-margin, and low-cyclicality segments. The BA is a pillar of Clariant’s efforts to be a supplier of green and sustainable products.
The Business AreaBusiness AreaFor the financial reporting, Clariant grouped its businesses in three core Business Areas: Care Chemicals, Catalysis, and Natural Resources. As of 1 January 2023, the Group conducts its business through the three newly formed Business Units Care Chemicals, Catalysts, and Adsorbents & Additives and will report accordingly as of the first quarter of 2023. Catalysis develops, manufactures, and sells a wide range of catalyst products for the chemical, fuel, and automotive industries, as well for the biofuel business. This BA experiences a cyclicality in line with the investment cycle of the petrochemical industry.
The Business AreaBusiness AreaFor the financial reporting, Clariant grouped its businesses in three core Business Areas: Care Chemicals, Catalysis, and Natural Resources. As of 1 January 2023, the Group conducts its business through the three newly formed Business Units Care Chemicals, Catalysts, and Adsorbents & Additives and will report accordingly as of the first quarter of 2023. Natural Resources, comprising the BUs Oil & Mining Services, Functional Minerals and Additives is characterized by high growth and a low cyclicality. Main drivers are the rising demand for high value-added specialty chemicals used in the oil, mining, food and packaging industries, the increased consumption of oil, gas and base metals; and the increasing use of plastics with tailor-made properties in applications such as mobile phones, cars, and construction, driven by the fast-growing economies.
Discontinued operations comprise the Business Unit PigmentsPigmentsPigments are substances used for coloring; they are used in a technical manner, for example in the manufacture of dyes, varnishes, and plastics. In 2020, Clariant launched the divestment process of its Pigments business, which was completed on 3 January 2022. (in 2021).
Corporate: Income and expenses relating to Corporate include the costs of the corporate headquarters and some of the corporate coordination functions in major countries. In addition, Corporate includes certain items of income and expense that are not directly attributable to specific business areas, like central R&D costs.
The Group’s business areas are segments offering a large variety of products. The segments are managed separately because they manufacture, distribute, and sell distinct products that require differing technologies and marketing strategies. These products are also subject to risks and returns that are different from those of other segments.
Segment sales are sales reported in the Group’s income statement directly attributable to a segment, as well as the relevant portion of the company income that can be allocated on a reasonable basis to a segment, whether from sales to external customers or from transactions with other segments.
Segment operating expenses are expenses resulting from the operating activities of a segment directly attributable to the segment and the relevant portion of an expense that can be allocated on a reasonable basis, including expenses relating to sales to external customers and expenses relating to transactions with other segments. Inter-segment transactions are entered into under the normal circumstances and terms and conditions that would also be available to unrelated third parties.
The segment net assets consist of segment assets - primarily property, plant, and equipment, intangible assets, inventories and receivables - less segment liabilities. Usually no allocation of Corporate items is made to the segments. Corporate assets and liabilities principally consist of net liquidity (cash, cash equivalents, and other current financial assets less financial debts) and deferred and current income taxes. Interest income, interest expense, and taxes are not allocated to the segments.
The Executive Steering CommitteeExecutive Steering CommitteeThe Executive Steering Committee (ESC) is authorized by the Board of Directors to steer the company. It has overall strategic and financial responsibility, including for our profit and loss statement. The ESC consists of the Chief Executive Officer (CEO), the Chief Financial Officer (CFO), and the three Business Presidents. assesses the performance of the operating segments based on income statement parameters like third-party sales, EBITDAEBITDAEarnings before interest, taxes, depreciation, and amortization., operating result, and cash flow. The return on the capital invested in each segment is measured by the Return on Net Assets (RONA).
1.26 – Share capital and other reserves
All issued shares are ordinary shares and, as such, are classified as equity. Incremental costs, directly attributable to the issue of new shares or options, are shown in equity as a deduction, net of tax, from the proceeds.
Written put options where Clariant Ltd shares are the underlying are reported as obligations to purchase Clariant Ltd shares if the number of shares is fixed and physical settlement for a fixed amount of cash is required in case the option is exercised.
At inception, the obligation is recorded at the present value of the settlement amount of the option, and the corresponding effect is recognized in shareholders’ equity. The liability is measured subsequently at amortized costs using the effective interest method. Upon settlement of such written put options, the liability is extinguished, and the charge to equity is reclassified to the treasury shares.
Clariant Ltd shares, subject to such put options, are not considered to be outstanding for the purpose of basic earnings per share calculations, but are considered for the dilutive earnings per share calculations to the extent that they are dilutive.
Other reserves comprise the following items:
- Share premium: The share premium comprises the excess price paid over the par value of the share at the time of issuance of the share capital.
- Cumulative translation reserves: The translation reserves comprise the foreign exchange differences arising from the translation of the financial statements of the foreign subsidiaries stated in a currency other than the Group’s functional currency. In addition, the cumulative translation reserves comprise the foreign exchange differences arising on the translation of financial liabilities denominated in a currency other than the functional currency of the parent company, Clariant Ltd, that are at the same time designated as a hedge of a net investment in a foreign entity.
1.28 – Financial debt
Financial debt is recognized based on the requirements of IFRSIFRSThe International Financial Reporting Standards (IFRS) are international accounting standards. 9, Financial Instruments: Recognition and Measurement.
Financial debt is valued at amortized cost.
1.29 – Financial assets
Financial assets are classified, recognized, measured, and, if necessary, impaired based on the requirements of IFRSIFRSThe International Financial Reporting Standards (IFRS) are international accounting standards. 9, Financial Instruments.
Financial assets are valued at amortized cost if there is the intention to hold them in order to collect the contractual cash flow, and this cash flow is only for the principal and interest.
Financial assets are valued at fair value through other comprehensive income when they are held with the intention of getting the contractual cash flow, but also with the intention of eventually selling the asset.
Equity investments are measured at fair value through other comprehensive income based on the Group’s irrevocable election at initial recognition.
There are currently no financial assets at fair value though profit or loss.
Loss allowances are recognized for expected credit losses, in line with the requirements of IFRSIFRSThe International Financial Reporting Standards (IFRS) are international accounting standards. 9, Financial Instruments. Changes in the measurement of the loss allowance are recognized in profit or loss.
Purchases and sales of financial assets are recognized on the settlement date, which is the date on which the Group receives or delivers the assets.
1.30 – Business combinations
The Group applies the acquisition method to account for business combinations in accordance with IFRSIFRSThe International Financial Reporting Standards (IFRS) are international accounting standards. 3, Business Combinations, and recognizes any non-controlling interests in the acquiree at fair value (full goodwill method).
Acquisition-related costs are expensed as incurred.
2. Enterprise Risk Management Identification, Assessment, and Management
In the framework of the Enterprise Risk Management Policy, risk assessments are prepared by business units, global functions and corporate functions to assess threats that will impact the achievement of the objectives set for Clariant overall. These objectives are a result of the overall strategy of the Group as set by the Board of Directors and implemented by the Executive Steering CommitteeExecutive Steering CommitteeThe Executive Steering Committee (ESC) is authorized by the Board of Directors to steer the company. It has overall strategic and financial responsibility, including for our profit and loss statement. The ESC consists of the Chief Executive Officer (CEO), the Chief Financial Officer (CFO), and the three Business Presidents..
The Executive Steering CommitteeExecutive Steering CommitteeThe Executive Steering Committee (ESC) is authorized by the Board of Directors to steer the company. It has overall strategic and financial responsibility, including for our profit and loss statement. The ESC consists of the Chief Executive Officer (CEO), the Chief Financial Officer (CFO), and the three Business Presidents. is responsible for monitoring the risk assessments for relevance and consistency. The Executive Steering CommitteeExecutive Steering CommitteeThe Executive Steering Committee (ESC) is authorized by the Board of Directors to steer the company. It has overall strategic and financial responsibility, including for our profit and loss statement. The ESC consists of the Chief Executive Officer (CEO), the Chief Financial Officer (CFO), and the three Business Presidents. has formed an »Ethics and Risk Management« subcommittee, which maintains an up-to-date understanding of areas where Clariant is, or may be, exposed to risk issues, and seeks to ensure that Management is effectively addressing those issues. The Ethics and Risk Management Committee meets on a quarterly basis.
The short- and long-term objectives are set in the fourth quarter of the year. These objectives and threats are subject to scrutiny by the Executive Steering CommitteeExecutive Steering CommitteeThe Executive Steering Committee (ESC) is authorized by the Board of Directors to steer the company. It has overall strategic and financial responsibility, including for our profit and loss statement. The ESC consists of the Chief Executive Officer (CEO), the Chief Financial Officer (CFO), and the three Business Presidents. during meetings with each business unit. Also reviewed and discussed are proposed measures to reduce or contain threats. In that context, responsibilities are assigned. All stakeholders are required to report significant changes to existing identified risks and new threats as they arise. Risk registers are maintained using financial and reputational impact and probability assessments to score and rank all identified risks. The assessment also addresses the measures to be taken to manage the risk.
When threats have been identified and quantified, they are delegated to qualified individuals who are required to deliver effective risk management. Depending on the nature of the risk identified, specific skill sets may be required for the management of those particular risks.
A summary risk assessment is submitted annually to the Executive Steering CommitteeExecutive Steering CommitteeThe Executive Steering Committee (ESC) is authorized by the Board of Directors to steer the company. It has overall strategic and financial responsibility, including for our profit and loss statement. The ESC consists of the Chief Executive Officer (CEO), the Chief Financial Officer (CFO), and the three Business Presidents., the Audit Committee and the Board of Directors for review.
In the event of new or changed risks, reporting is accelerated and a regular follow-up on mitigation measures is implemented. To support functional responsibility, certain functions have access to risk assessments to assist them in their roles.
Examples of such functions are Environmental Safety & Health Affairs (ESHA), to identify key sites for their property risk survey program, or Group Procurement, to ensure reliable and compliant supply of raw materials.
Examples of emerging risks included in the risk register:
2.1 – Regulation & Compliance
Clariant is subject to many rules and regulations, as well as compliance standards. These include chemical industry, country, government, and customer requirements as well as the European Union’s (EU) Regulations on Registration, Evaluation, Authorization, and Restriction of Chemicals (REACH) and similar regulations in other countries.
The function Global Product Stewardship is responsible for ensuring that all relevant legal requirements are met. Certain specific matters are delegated to other functions.
2.2 – Sites and locations
This includes manufacturing plants and equipment important for the production of Clariant products for sale to customers.
Also addressed are country and culture issues that could create threats to business objectives. The aim is to maintain high-quality and safe production facilities. ESHA and Regional Services are responsible for the management of the associated risks.
2.3 – Cyber and information security
Successful performance of the Clariant Group depends on properly working information systems. Cyberattacks may result in the loss of business and personal data, knowledge, facilities, or money, leading to interruptions in manufacturing and product deliveries. Clariant is responding to the increased cyber risk with a reinforced information security department, state-of-the-art software, and frequent awareness campaigns.
Examples of emerging risks included in the risk register:
Geopolitical and macroeconomic development
The achievement of corporate targets depends on global economic and political developments, which are continuously monitored in all markets. Economic uncertainty has increased, and the growth of the global economy could be lower than expected due to geopolitical tensions and/or global recession. Clariant is responding to the adverse economic environment with various performance programs addressing both cost and revenues.
Energy price increases and shortages
The Clariant Group requires energy from various sources for use in production facilities with strong reliance on oil, natural gas, and electricity. Costs for natural gas and energy in general constitute a relevant proportion of the production and raw material costs. Clariant may not be able to pass on increasing energy costs to its customers in time or at all. In addition, shortages or the unavailability of certain types of energy could interrupt the production processes, especially in Germany, thereby materially and adversely impacting the Group’s ability to conduct its business and to produce its products. Clariant is closely monitoring the situation to secure supply, mitigate price increases, and strictly manage margins.
3. Financial risk management
3.1 – Financial risk factors
The Group’s activities expose it to a variety of financial risks: market risk (including foreign exchange risk, interest rate risk and price risk), credit risk, liquidity risk, counterparty risk, (re-)financing and funding risk as well as settlement risk. The Group’s overall risk management program focuses on the unpredictability of financial markets and seeks to reduce potential adverse effects on the Group’s financial performance at reasonable hedging costs. The Group uses derivative financial instruments, nonderivative financial instruments, and operating strategies to hedge certain risks.
Financial risk management is carried out by the central treasury department (Corporate Treasury) under policies approved by the Executive Steering CommitteeExecutive Steering CommitteeThe Executive Steering Committee (ESC) is authorized by the Board of Directors to steer the company. It has overall strategic and financial responsibility, including for our profit and loss statement. The ESC consists of the Chief Executive Officer (CEO), the Chief Financial Officer (CFO), and the three Business Presidents. and the Board of Directors. Corporate Treasury identifies, evaluates, and hedges financial risks in close cooperation with the Group’s operating units and functions. Written principles for the management of overall foreign exchange risk and credit risk for the use of derivative financial instruments and non-derivative financial instruments, as well as written principles for the investment of excess liquidity (counterparty risk), are in place.
3.1.1 – Market risk
3.1.1.1 – Foreign exchange risk
- Exposure to foreign exchange risk: The Group operates internationally and is exposed to foreign exchange risks arising from various currency exposures, primarily with respect to the euro, the US dollar, and, to some extent, the currencies of emerging countries. Foreign exchange risks arise from future commercial transactions, recognized assets and liabilities, and net investments in foreign operations when they are denominated in a currency that is not the respective subsidiary’s functional currency.
- Foreign exchange risk management: To manage the foreign exchange risk arising from future commercial transactions and recognized assets and liabilities, entities in the Group are allowed to use FX forward contracts, FX options, and FX swaps according to the Group’s foreign exchange risk policy. Corporate Treasury is responsible, in close coordination with the Group’s operating units, for managing the net position in each foreign currency and for putting in place the appropriate hedging actions. The Group’s foreign exchange risk management policy is to selectively hedge net transaction exposures in major foreign currencies. Currency exposures arising from the net assets of the Group’s foreign operations are managed primarily through borrowings denominated in the relevant foreign currency. Detailed information regarding foreign exchange management is provided in note 30.
- Foreign exchange risk sensitivity: The estimated percentage change of the following foreign exchange rates used in this calculation is based on the historical foreign exchange rate volatility for a term of 360 days.
- At 31 December 2022, if the euro had strengthened/weakened by 8 % (2021: 4 %) against the Swiss franc with all other variables held constant, pretax profit for the year would have been CHF 15 million lower/higher (2021: CHF 22 million lower/higher), mainly as a result of foreign exchange gains/losses on the translation of the euro-denominated financing, cash and cash equivalents, intragroup financing, and third-party trade receivables and payables. Equity would have been CHF 85 million higher/lower (2021: CHF 42 million higher/lower), arising mainly from foreign exchange gains/losses of the exposure of the foreign currency participations and the hedge instruments in the hedge of net investments, which partially offset this effect.
- At 31 December 2022, if the US dollar had strengthened/weakened by 10 % (2021: 6 %) against the Swiss franc with all other variables held constant, pretax profit for the year would have been CHF 2 million higher/lower (2021: CHF 13 million higher/lower), mainly as a result of foreign exchange gains/losses on the translation of US dollar-denominated cash and cash equivalents, intragroup financing, and trade receivables. Equity would have been CHF 76 million higher/lower (2021: CHF 60 million lower/higher), arising mainly from foreign exchange gains/losses of the exposure of the foreign currency participations and the hedge instruments in the hedge of net investments, which partially offset this effect.
3.1.1.2 – Interest rate risk
- Exposure to interest rate risk: Financial debt issued at variable rates and cash and cash equivalents expose the Group to cashflow interest rate risk; the net exposure as of 31 December 2022 was not significant. Financial debt issued at fixed rates does not expose the Group to fair value interest rate risk because it is recorded at amortized costs. At the end of 2022, the group had a net exposure on asset side, as a result of higher cash than financial debt issued at variable rates.
- Interest rate risk management: It is the Group’s policy to manage the costs of interest using fixed- and variable-rate debt and interest-related derivatives. Corporate Treasury monitors the net debt fix-to-float mix on an ongoing basis.
- Interest rate risk sensitivity: To calculate the impact of a potential interest rate shift on profit or loss, the net debt exposure is taken into consideration for cash and debt maturing within the next 12 months. The variable certificates of indebtedness maturing after 12 months are also taken into consideration (interest rates comparison between the end of 2022 and end of 2021). At 31 December 2022, if the CHF interest rates on net current financial debt, including certificates of indebtedness with variable interest rates after 12 months, had been 1 basis point higher/lower with all other variables held constant, pretax profit for the year would have been CHF 1.21 million higher/lower (2021: CHF 0.00 million higher/lower for a CHF interest rate shift of 1 basis point).
At 31 December 2022, if the USD interest rates on net current financial debt issued, including certificates of indebtedness with variable interest rates after 12 months, had been 1 basis point higher/lower with all other variables held constant, pretax profit for the year would have been CHF 0.16 million lower/higher (2021: CHF 0.15 million lower/higher for a USD interest rate shift of 1 basis point). At 31 December 2022, if the EUR interest rates on net current financial debt issued, including certificates of indebtedness with variable interest rates after 12 months, had been 1 basis point higher/lower with all other variables held constant, pretax profit for the year would have been CHF 1.70 million higher/lower (2021: CHF 5.09 million higher/lower for a euro interest rate shift of 1 basis point).
3.1.2 – Other price risks
With regard to the financial statements as of 31 December 2022 and 2021, the Group was not exposed to other price risks in the sense of IFRSIFRSThe International Financial Reporting Standards (IFRS) are international accounting standards. 7, Financial Instruments: Disclosures, except for the one related to small scale participations in companies. Please refer to note 9.
3.1.2.1 – Credit risk
- Exposures to credit risk: credit risk arises from deposits of cash and cash equivalents, from entering into derivative financial instruments, and from deposits with banks and financial institutions, as well as from credit exposures to wholesale and retail customers, including outstanding receivables and committed transactions with suppli ers. Customer credit risk exposure is triggered by customer default risk and country risk. As of 31 December 2022, the Group had a diversified portfolio with more than 15 000 active credit accounts (2021: more than 16 000), with no significant concentration either due to size of customers or due to country risk. 55 % (2021: 50 %) of the accounts receivable are distributed among 275 (2021: 244) corporate groups with moderate customer default risk.
- Credit risk management: Clariant has a Group credit risk policy in place to ensure that sales are made to customers only after an appropriate credit assessment. Procedures are standardized within a corporate customer credit risk policy and supported by the IT system with respective credit management tools. Credit lines are partially backed by credit risk insurance.
Ageing balance of trade receivables
31.12.2022 | 31.12.2021 | |||
---|---|---|---|---|
Not due yet | 91 % | 93 % | ||
Total overdue | 9 % | 7 % | ||
– less than 30 days | 6 % | 4 % | ||
– more than 30 days | 3 % | 3 % |
Net trade receivables per Group internal risk category
31.12.2022 | 31.12.2021 | |||
---|---|---|---|---|
A – low credit risk | 24 % | 24 % | ||
B – low to medium credit risk | 34 % | 31 % | ||
C – medium to above-average risk | 29 % | 32 % | ||
D – high credit risk | 12 % | 13 % | ||
N – customers awaiting rating | 0 % | 0 % |
Financial instruments contain an element of risk that the counterparty may be unable to either issue securities or to fulfill the settlement terms of a contract. Clariant therefore – whenever possible – only cooperates with counterparties or issuers that are at least rated »BB-« when it comes to entering into deposits with such counterparties. The cumulative exposure to these counterparties is constantly monitored by Corporate Treasury. There is no expectation of a material loss due to counterparty risk.
The Group maintains a large EUR cash pooling structure with a leading European bank, over which most European subsidiaries execute their cash transactions denominated in euro. A USD cash pooling structure with a leading US bank was introduced in 2020. As a result of this cash pool, the Group at certain times has substantial current financial assets and at other times substantial current financial liabilities with the corresponding banks.
In view of the European bank being rated »A-« (2021: A-) and the US bank being rated »A+« by the most important rating agencies, Clariant does not consider this to pose any particular counterparty risk.
At the balance sheet date, 80 % (2021: 71 %) of the total cash and cash equivalents and short-term deposits were held with five banks (2021: five banks), each with a position between CHF 42 million and CHF 202 million (2021: between CHF 21 million and CHF 132 million). All of these banks are rated »A-« (2021: »A-«) and better.
The table below shows in percentage of total cash and cash equivalents the share deposited with each of the three major counterparties at the balance sheet date (excluding the banks managing the EUR and the USD cash pools):
Counterparty | Rating | 31.12.2022 | ||
---|---|---|---|---|
Bank 1 | A- | 25 % | ||
Bank 2 | A+ | 10 % | ||
Bank 3 | AA+ | 6 % |
Counterparty | Rating | 31.12.2021 | ||
---|---|---|---|---|
Bank 1 | A+ | 20 % | ||
Bank 2 | A+ | 7 % | ||
Bank 3 | A+ | 5 % |
3.1.3 – Liquidity risk
- Liquidity risk management: Cash flowCash flowEconomic indicator representing the operational net inflow of cash and cash equivalents during a given period. forecasting is performed in the subsidiaries of the Group and in aggregate by Corporate Treasury. Corporate Treasury monitors the forecasts of the Group’s liquidity requirements to ensure it has sufficient cash to meet its operational needs while maintaining sufficient headroom on its undrawn borrowing facilities. At all times, the Group aims to meet the requirements set by the covenants of any of its borrowing facilities. Corporate Management therefore takes into consideration the Group’s debt financing plans and financing options.
Cash that is not needed in the operating activities of the Group is invested in short-term money market deposits or marketable securities if an interest income higher than the one on a regular bank deposit can be achieved. At 31 December 2022, the Group held money market funds of CHF 354 million (2021: CHF 29 million), of which CHF 324 million have an initial tenor of more than 90 days (2021: CHF 12 million).
The following table analyzes the maturity profile of the Group’s financial liabilities. The amounts disclosed are the contractual undiscounted cash flows and therefore do not reconcile with the financial liabilities presented in the consolidated balance sheets.
At 31 December 2022 in CHF m | Less than 1 year | Between 1 and 2 years | Between 2 and 5 years | Over 5 years | ||||
---|---|---|---|---|---|---|---|---|
Borrowings | 355 | 266 | 563 | 17 | ||||
Interest on borrowings | 19 | 15 | 24 | – | ||||
Lease liabilities | 46 | 32 | 67 | 99 | ||||
Trade payables and other liabilities | 1 009 | 4 | 10 | 41 | ||||
Derivative financial instruments | – | 8 | 17 | – |
At 31 December 2021 in CHF m | Less than 1 year | Between 1 and 2 years | Between 2 and 5 years | Over 5 years | ||||
---|---|---|---|---|---|---|---|---|
Borrowings | 707 | 272 | 655 | 18 | ||||
Interest on borrowings | 21 | 13 | 17 | 1 | ||||
Lease liabilities | 50 | 40 | 78 | 121 | ||||
Trade payables and other liabilities | 1122 | 4 | 10 | 44 | ||||
Derivative financial instruments | 8 | – | 14 | – |
The Group covers its liabilities out of generated operating cash flow, liquidity reserves in form of cash and cash equivalents, including money market deposits (31 December 2022: CHF 718 million vs. 31 December 2021: CHF 427 million), out of uncommitted open cash pool limits and bank credit lines (31 December 2022: CHF 114 million vs. 31 December 2021: CHF 117 million), as well as out of additional uncommitted net working capital facilities and the issuance of capital market instruments.
Since 16 December 2016, Clariant Ltd had an agreement for a CHF 445 million (2021: CHF 445 million) five-year multicurrency revolving credit facility (RCF) with two one-year extension options. The RCF is structured as a club deal with ten key relationship banks with equal stakes and contains an accordion option for an increase up to CHF 600 million. The RCF is structured as a »backstop« facility for rating purposes to maintain Clariant’s liquidity headroom. It contains customary covenants such as negative pledge, cross default, ownership change, and restriction on disposals, mergers, and subsidiary debt. The Group is required to maintain one financial covenant (debt leverage) that is tested at the end of each financial half year. The RCF has been extended until 16 December 2023. Clariant is in the process of negotiating a new RCF which will replace the existing one.
3.2 – Fair value measurement
IFRSIFRSThe International Financial Reporting Standards (IFRS) are international accounting standards. 13, Fair Value Measurement, requires the disclosure of fair value measurements for financial instruments measured at fair value in the balance sheet in accordance with the fair value measurement hierarchy.
Carrying amounts and fair values of financial instruments by category:
Financial instruments by assets class
At 31 December 2022 in CHF m | Financial instruments mandatorily at fair value through profit or loss | Financial instruments at fair value through OCI | Fair value - hedging instruments | Financial assets at amortized cost | Financial liabilities at amortized cost | Carrying amount | Fair value | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Trade receivables | – | – | – | 725 | – | 725 | 725 | |||||||
Short-term deposits | – | – | – | 324 | – | 324 | 324 | |||||||
Cash and cash equivalents | – | – | – | 394 | – | 394 | 394 | |||||||
Non-current financial assets (vendor loan) | – | 186 | – | 39 | – | 225 | 225 | |||||||
Derivative financial instruments | – | – | 2 | – | – | 2 | 2 | |||||||
Total financial assets | – | 186 | 2 | 1 482 | – | 1 670 | 1 670 | |||||||
Trade payables and other liabilities | – | – | – | – | 1 009 | 1 009 | 1 009 | |||||||
Straight bonds | – | – | – | – | 535 | 535 | 529 | |||||||
Other debt | – | – | – | – | 665 | 665 | 665 | |||||||
Current lease liabilities | – | – | – | – | 44 | 44 | 44 | |||||||
Non-current lease liabilities | – | – | – | – | 195 | 195 | 195 | |||||||
Liabilities associated with assets held for sale | – | – | – | – | 6 | 6 | 6 | |||||||
Derivative financial instruments | – | – | 25 | – | – | 25 | 25 | |||||||
Total financial liabilities excl. trade payables and other liabilities | – | – | 25 | – | 1 445 | 1 470 | 1 464 | |||||||
Total financial liabilities | – | – | 25 | – | 2 454 | 2 479 | 2 473 |
The fair value hierarchies are defined as follows:
- Level 1: Quoted prices (unadjusted) in active markets for identical assets or liabilities.
- Level 2: Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly (that is, as prices) or indirectly (that is, derived from prices).
- Level 3: Inputs for the asset or liability that are not based on observable market data (that is, unobservable inputs).
3.2.1 – Valuation methods
As of 31 December 2022, the open derivative financial instruments held were valued using the following valuation methods:
Forward exchange rate contracts: The valuations of forward exchange rate contracts are based on the discounted cash flow model, using observable inputs such as interest curves and spot rates.
Exchange rate options: FX options are valued based on a Black-Scholes model, using major observable inputs such as volatility and exercise prices.
Equity investments valued at fair value through OCI: These are usually classified at Level 3. Their valuation is based on multiples of projected earnings and discounted cash flows.
The financial instruments measured at fair value through profit or loss were all classified as Level 2 (see note 30). There were no transfers between the levels in 2022 and 2021.
3.3 – Hedge accounting
Derivatives are initially recognized at fair value on the date a derivative contract is entered into and are subsequently remeasured to their fair value at the end of each reporting period. The accounting for subsequent changes in fair value depends on whether the derivative is designated as a hedging instrument, and if so, the nature of the item being hedged. The Group designates certain derivatives as either:
- Hedges of a particular risk associated with the cash flows of recognized assets and liabilities and highly probable forecast transactions (cash flow hedges)
- Hedges of a net investment in a foreign operation (net investment hedges).
At the inception of the hedge relationship, the Group documents the economic relationship between hedging instruments and hedged items, including whether changes in the cash flows of the hedging instruments are expected to offset changes in the cash flows of hedged items. The Group documents its risk management objective and strategy for undertaking its hedge transactions.
The fair values of derivative financial instruments designated in hedge relationships are disclosed in note 30. Movements in the hedging reserve in shareholders’ equity are shown in note 30. The full fair value of a hedging derivative is classified as a non-current asset or liability when the remaining maturity of the hedged item is more than 12 months; it is classified as a current asset or liability when the remaining maturity of the hedged item is less than 12 months. Trading derivatives are classified as a current asset or liability.
- Cash flowCash flowEconomic indicator representing the operational net inflow of cash and cash equivalents during a given period. hedges: The effective portion of changes in the fair value of derivatives that are designated and qualify as cash flow hedges is recognized within equity. The gain or loss relating to the ineffective portion is recognized immediately in profit or loss. As long as the hedged cash flow item is probable, the cumulative gain or loss on the respective hedge remains in equity and does not get recycled.
Amounts accumulated in equity are reclassified in the periods when the hedged item affects profit or loss, as follows:
- The gain or loss relating to the effective portion of the interest rate/cross-currency swaps hedging variable-rate or fixed-rate borrowings is recognized in profit or loss within finance cost at the same time as the interest expense on the hedged borrowings.
- When a hedging instrument expires or is sold or terminated, or when a hedge no longer meets the criteria for hedge accounting, the cumulative gain or loss that was reported in equity is immediately reclassified to profit or loss.
- Hedges of net investments in foreign operations are accounted for similarly to cash flow hedges. Any gain or loss on the hedging instrument relating to the effective portion of the hedge is recognized in other comprehensive income and accumulated within equity. The gain or loss relating to the ineffective portion is recognized immediately in profit or loss.
Gains and losses accumulated in equity are reclassified to profit or loss when the foreign operation is partially disposed of or sold.
3.4 – Capital risk management
The Group’s objectives when managing capital are to safeguard the ability to continue as a going concern in order to provide returns for the shareholders and benefits for other stakeholders and to maintain a capital structure suitable to optimize the cost of capital. This includes aspects of the credit rating.
In order to maintain or adjust the capital structure, the Group may adjust the amount of payouts to the shareholders, return capital to the shareholders, issue new shares, or sell assets to reduce debt. The Group monitors capital on the basis of invested capital as part of the return on invested capital concept. Invested capital is calculated as the sum of total equity as reported in the consolidated balance sheet plus current and non-current financial liabilities as reported in the consolidated balance sheet, including lease liabilities, plus estimated cash needed for operating purposes, less cash and cash equivalents and near cash assets not needed for operating purposes.
Invested capital for the Group was as follows on 31 December 2022 and 2021 respectively:
in CHF m | 2022 | 2021 | ||
---|---|---|---|---|
Total equity | 2 524 | 2 544 | ||
Total current and non-current financial liabilities (incl. lease liabilities, excl. trade payables and other liabilities) | 1 464 | 1 949 | ||
Less cash and cash equivalents and short-term deposits 1 | –718 | –427 | ||
Less assets held for sale (net of liabilities related to assets held for sale) | –44 | –581 | ||
Cash needed for operating purposes | 104 | 87 | ||
Invested capital | 3 330 | 3 572 | ||
1 Short-term deposits represent deposits over 90 days.
|
At the end of 2022, Clariant considers the invested capital to be adequate.
3.5 – LIBOR Reform
On 31 December 2021, LIBOR rates for all major currencies except for the US dollar were abandoned and replaced by alternative risk-free rates (ARFRs, e.g., SARON for CHF, SONIA for GBP and, TONAR for JPY). ARFRs are transaction-based on overnight rates (secured or unsecured). The loan documentation of Clariant’s revolving credit facility (RCF) has been amended for the switch from LIBOR to ARFRs for the relevant currencies. No other financial liabilities or derivatives were affected by the discontinuation of LIBOR. All of Clariant’s floating certificates of indebtedness are denominated in EUR and therefore subject to EURIBOR, which continues to be used.
4. Critical accounting estimates and judgments
Estimates and judgments are continually evaluated and are based on historical experience and other factors, including expectations about future events that are believed to be reasonable under the circumstances.
The Group makes estimates and assumptions concerning the future. The resulting accounting estimates will, by definition, seldom equal the related actual results. The estimates and assumptions that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year are discussed below.
4.1 – Estimated impairment of goodwill
The Group tests annually whether goodwill has suffered any impairment in accordance with the requirements of IAS 36, Impairment of Assets. The recoverable amounts of all cash-generating units have been determined based on value-in-use calculations reported in continuing operations. The recoverable amounts of cash-generating units classified as discontinued operations as well as of the assets and liabilities classified as held for sale have been valued at fair value less cost to sell.
4.2 – Environmental liabilities
The Group is exposed to environmental regulations in numerous jurisdictions. Significant judgment is required in determining the worldwide provision for environmental remediation. The Group constantly monitors its sites to ensure compliance with legislative requirements and to assess the liability arising from the need to adapt to changing legal demands. The Group recognizes liabilities for environmental remediation based on the latest assessment of the environmental situation of the individual sites and the most recent requirements of the respective legislation.
Where the final remediation results in expenses that differ from the amounts previously recorded, such differences impact the income statement in the period in which such determination is made.
4.3 – Income tax and other taxes
The Group is subject to income tax and other taxes in numerous jurisdictions. Significant judgment is required in determining the worldwide provision for income tax and other taxes. There are many transactions and calculations for which the ultimate tax determination is uncertain at the time a liability must be recorded.
The Group recognizes liabilities for anticipated tax audit issues based on estimates of whether additional taxes will be due. Where the final tax outcome of these matters is different from the amounts initially recorded, such differences impact the income tax and deferred tax provisions in the period in which such determination is made (see note 10). As a substantial part of Clariant’s activities are based in Germany, this is where the largest tax risks arise.
Some subsidiaries generate tax losses. Often these can be used to offset taxable gains of subsequent periods. The Group constantly monitors the development of such tax loss situations. Based on the business plans for the subsidiaries concerned, the recoverability of such tax losses is determined. In the event that a tax loss is deemed to be recoverable, the capitalization of a deferred tax asset for such a tax loss is then decided.
4.4 – Estimates for the accounting for employee benefits
IAS 19, Employee Benefits, requires that certain assumptions are made in order to determine the amount to be recorded for retirement benefit obligations and pension plan assets, in particular for defined -benefit plans. These are mainly actuarial assumptions such as expected future salary increases, long-term increase in healthcare costs, average life expectancy, and discount rates. Substantial changes in the assumed development of any of these variables may significantly change the Group’s retirement benefit obligation and pension assets (see note 20).
4.5 – Provisions and contingencies
Clariant is regularly confronted with situations where possible obligations arising from past events will only be confirmed by the occurrence or non-occurrence of future events not wholly within the control of the Group or where the amount of the obligation cannot be reliably estimated. Clariant reviews such situations at each balance sheet date and makes judgments based on all information available to determine if an outflow of resources can be reliably estimated or not. If this is not possible, a contingency is reported for each material case.
4.6 – Assets held for sale and liabilities directly associated with assets held for sale
As a result of the decision to divest the business unit PigmentsPigmentsPigments are substances used for coloring; they are used in a technical manner, for example in the manufacture of dyes, varnishes, and plastics. In 2020, Clariant launched the divestment process of its Pigments business, which was completed on 3 January 2022., Clariant reclassified the assets and liabilities pertaining to those activities to »held for sale« in accordance with IFRSIFRSThe International Financial Reporting Standards (IFRS) are international accounting standards. 5 (see note 1.03). In distinguishing between the assets and liabilities pertaining to continuing operations and those pertaining to discontinued operations, judgment had to be applied, as a part of those assets and liabilities is used by both types of activities.
All assets and liabilities exclusively pertaining to one business unit were allocated to that business unit. In all other cases, a critical assessment was conducted as to whether it could be reasonably expected that the asset or liability concerned would be transferred in a disposal. This assessment was made based on past experience and most recent market developments. The allocation made may have to be adjusted when the disposal is actually consummated.
5. Property, plant and equipment
in CHF m | Land | Buildings | Machinery and equipment | Furniture, vehicles, computer hardware | Assets under construction | Total 2022 | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Cost | ||||||||||||
As per 1 January | 265 | 943 | 2 082 | 291 | 400 | 3 981 | ||||||
Additions | 1 | 9 | 52 | 13 | 134 | 209 | ||||||
Acquired in business combinations (see note 26) | 8 | 43 | 11 | 1 | – | 63 | ||||||
Reclassified to/from held for sale (see note 25) | –3 | –38 | –57 | –11 | –4 | –113 | ||||||
Disposals | –2 | –9 | –55 | –21 | –1 | –88 | ||||||
Reclassifications | 12 | 77 | 232 | 17 | –337 | 1 | ||||||
Exchange rate differences | –11 | –26 | –54 | –10 | –14 | –115 | ||||||
At 31 December | 270 | 999 | 2 211 | 280 | 178 | 3 938 | ||||||
Accumulated depreciation and impairment | ||||||||||||
As per 1 January | –75 | –468 | –1 421 | –227 | – | –2 191 | ||||||
Reclassified to/from held for sale (see note 25) | – | 29 | 45 | 10 | – | 84 | ||||||
Disposals | – | 7 | 48 | 20 | – | 75 | ||||||
Depreciation | – | –36 | –130 | –18 | – | –184 | ||||||
Impairment (see note 27) | – | –65 | –170 | –1 | – | –236 | ||||||
Exchange rate differences | 4 | 16 | 37 | 6 | – | 63 | ||||||
At 31 December | –71 | –517 | –1 591 | –210 | – | –2 389 | ||||||
Net book value | 199 | 482 | 620 | 70 | 178 | 1 549 |
Impairments recognized in the income statement amounted to CHF 236 million in 2022 (2021: CHF 1 million) of which CHF 220 million relate to the bioethanol plant in Podari, Romania. This impairment is a consequence of the challenges encountered by Clariant in the ramp-up and industrialization of the new technology developped in Podari and the financial performance of the plant.
Additionally, an impairment of CHF 13 million was recognised on the property, plant and equipment pertaining to the North America Land Oil business to reflect the estimated fair value of that business for which a sale agreement was signed with Dorf Ketal during 2022.
Additional impairments regarding this activity were recorded in intangibles and goodwill. See note 6.
Finally, as a consequence of the Ukraine war, local assets were subject to impairment in the course of 2022 (CHF 3 million).
The property, plant and equipment pertaining to the North America Land Oil business as well as the ones pertaining to the Quats business - to be disposed of in the course of 2023 - have been reclassified to held for sale.
Exchange rate differences mainly arise from the changes in the euro/Swiss franc, Chinese renmimbi/Swiss franc, US dollar/Swiss franc and Romanian Leu/Swiss franc exchange rates. All these currencies significantly devalued against the Swiss franc in 2022.
As at 31 December 2022, commitments for the purchase of property plant and equipment concerned various projects mainly in Germany, China and US and totalled CHF 54 million (2021: CHF 78 million). As of 31 December 2022, property, plant and equipment acquired by way of business acquisition, with costs of CHF 63 million (2021: CHF 49 million) were recorded. See also note 26.
Additions in 2022 include CHF 48 million of investments in a second production line for halogen-free flame retardants in Daya Bay, China, currently under construction.
in CHF m | Land | Buildings | Machinery and equipment | Furniture, vehicles, computer hardware | Assets under construction | Total 2021 | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Cost | ||||||||||||
As per 1 January | 293 | 881 | 1 924 | 274 | 351 | 3 723 | ||||||
Additions | 1 | 14 | 51 | 17 | 279 | 362 | ||||||
Acquired in business combinations (see note 26) | 4 | 2 | 42 | 1 | – | 49 | ||||||
Reclassified to/from held for sale (see note 25) | – | – | 7 | 2 | –4 | 5 | ||||||
Disposals | –26 | –13 | –16 | –12 | –1 | –68 | ||||||
Reclassifications | 3 | 71 | 129 | 14 | –217 | – | ||||||
Exchange rate differences | –10 | –12 | –55 | –5 | –8 | –90 | ||||||
At 31 December | 265 | 943 | 2 082 | 291 | 400 | 3 981 | ||||||
Accumulated depreciation and impairment | ||||||||||||
As per 1 January | –78 | –454 | –1 343 | –220 | – | –2 095 | ||||||
Reclassified to/from held for sale (see note 25) | – | – | –3 | –2 | – | –5 | ||||||
Disposals | – | 12 | 15 | 12 | – | 39 | ||||||
Depreciation | – | –33 | –117 | –20 | – | –170 | ||||||
Impairment (see note 27) | – | – | –1 | – | – | –1 | ||||||
Exchange rate differences | 3 | 7 | 28 | 3 | – | 41 | ||||||
At 31 December | –75 | –468 | –1 421 | –227 | – | –2 191 | ||||||
Net book value | 190 | 475 | 661 | 64 | 400 | 1 790 |
Investment properties (Clariant as a lessor in operating leases)
As a result of the continuous efforts to increase efficiency and to optimize the structure of its facilities, sometimes production or administrative sites are vacated. In order to minimize expenses, Clariant seeks to find tenants for these facilities.
As a consequence, such facilities, which generate income exclusively from rental contracts, are considered as investment property in line with the requirements of IAS 40, Investment Property. All investment properties are valued at cost less depreciation.
At the end of 2022, investment properties are almost entirely located in Germany and Switzerland. The gross book value of investment property amounted to CHF 303 million on 31 December 2022 (CHF 304 million on 31 December 2021).
Accumulated depreciation on investment property amounted to CHF 183 million on 31 December 2022 (CHF 186 million on 31 December 2021).
The net book value amounted to CHF 120 million on 31 December 2022 (CHF 118 million on 31 December 2021).
Depreciation amounted to CHF 2 million in 2022 (CHF 1 million in 2021).
Income from investment properties amounted to CHF 9 million in 2022 (CHF 6 million in 2021) and is recorded in SG&A in the segment «Corporate».
Expected minimum lease income varies between CHF 6 million and CHF 8 million (2021: CHF 5 million and CHF 6 million) per annum for the next five years and amounts to CHF 158 million for later periods (2021: CHF 199 million).
Since all investment property consists of industrial and administrative sites that have been in use for several decades, there is no active market that would give information on possible market prices. The fair values of the investment properties were therefore determined by way of external appraisals and value-in-use calculations. As of 31 December 2022, the estimated fair value of investment properties amounted to CHF 185 million (CHF 171 million as of 31 December 2021).
6. Intangible assets
in CHF m | Goodwill | Technology | Customer relationships | Trade names | Other | Total 2022 | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Cost | ||||||||||||
As per 1 January | 1 052 | 228 | 371 | 91 | 303 | 2 045 | ||||||
Additions | – | – | – | – | 3 | 3 | ||||||
Acquired in business combinations (see note 26) | 1 | – | – | – | 1 | 2 | ||||||
Disposals | – | – | – | – | –3 | –3 | ||||||
Reclassified to held for sale (see note 25) | – | –27 | –96 | –5 | –10 | –138 | ||||||
Exchange rate differences | –33 | –4 | 2 | – | –7 | –42 | ||||||
At 31 December | 1 020 | 197 | 277 | 86 | 287 | 1 867 | ||||||
Accumulated amortization and impairment | ||||||||||||
As per 1 January | –5 | –189 | –268 | –86 | –217 | –765 | ||||||
Disposals | – | – | – | – | 2 | 2 | ||||||
Amortization | – | –7 | –13 | 1 | –19 | –38 | ||||||
Impairment (see note 27) | –152 | –11 | –61 | – | – | –224 | ||||||
Reclassified to held for sale (see note 25) | – | 27 | 96 | 5 | 10 | 138 | ||||||
Exchange rate differences | 7 | 3 | 1 | – | 6 | 17 | ||||||
At 31 December | –150 | –177 | –245 | –80 | –218 | –870 | ||||||
Net book value | 870 | 20 | 32 | 6 | 69 | 997 |
in CHF m | Goodwill | Technology | Customer relationships | Trade names | Other | Total 2021 | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Cost | ||||||||||||
As per 1 January | 998 | 231 | 368 | 86 | 288 | 1 971 | ||||||
Additions | – | – | – | – | 3 | 3 | ||||||
Acquired in business combinations (see note 26) | 60 | – | – | 5 | 26 | 91 | ||||||
Disposals | – | – | – | – | –7 | –7 | ||||||
Reclassified to held for sale (see note 25) | –1 | – | – | – | 3 | 2 | ||||||
Exchange rate differences | –5 | –3 | 3 | – | –10 | –15 | ||||||
At 31 December | 1 052 | 228 | 371 | 91 | 303 | 2 045 | ||||||
Accumulated amortization and impairment | ||||||||||||
As per 1 January | –4 | –182 | –251 | –83 | –213 | –733 | ||||||
Disposals | – | – | – | – | 3 | 3 | ||||||
Amortization | – | –9 | –16 | –3 | –15 | –43 | ||||||
Reclassified to held for sale (see note 25) | 1 | – | – | – | –1 | – | ||||||
Exchange rate differences | –2 | 2 | –1 | – | 9 | 8 | ||||||
At 31 December | –5 | –189 | –268 | –86 | –217 | –765 | ||||||
Net book value | 1 047 | 39 | 103 | 5 | 86 | 1 280 |
Amortization is allocated to the line in the income statement that represents the function to which the intangible asset pertains.
In 2022, impairment losses were recognized in the amount of CHF 224 million, mainly related to the North America Land Oil business to be disposed to Dorf Ketal in 2023. In 2021, no impairment losses were recognized.
The preliminary goodwill related to the acquisition of the US-based attapulgite business assets acquired from BASF amounted to CHF 1 million on 31 December 2022 (see note 26).
Impairment test for goodwill. Goodwill is allocated to the Group’s cash generating units (CGUs). Cash generating units consist of business units that, for external reporting purposes, are reported under the corresponding business areas under the corresponding business areas (reportable segments, see note 1.25).
Goodwill is allocated to the following CGUs:
in CHF m | 31.12.2022 | 31.12.2021 | ||
---|---|---|---|---|
Industrial & Consumer Specialties | 116 | 119 | ||
PigmentsPigmentsPigments are substances used for coloring; they are used in a technical manner, for example in the manufacture of dyes, varnishes, and plastics. In 2020, Clariant launched the divestment process of its Pigments business, which was completed on 3 January 2022. | – | 11 | ||
Functional Minerals | 133 | 137 | ||
Catalysts | 612 | 636 | ||
Oil & Mining Services | 9 | 155 | ||
Total net book value | 870 | 1 058 | ||
Thereof reclassified to held for sale: | ||||
PigmentsPigmentsPigments are substances used for coloring; they are used in a technical manner, for example in the manufacture of dyes, varnishes, and plastics. In 2020, Clariant launched the divestment process of its Pigments business, which was completed on 3 January 2022. | – | –11 | ||
Total as reported in the balance sheet | 870 | 1 047 |
The recoverable amount for CGUs reported as continuing operations is determined based on their value-in-use. The value-in-use calculations use cash flow projections based on the updated strategic plans up to 2025 as approved by the Executive Steering CommitteeExecutive Steering CommitteeThe Executive Steering Committee (ESC) is authorized by the Board of Directors to steer the company. It has overall strategic and financial responsibility, including for our profit and loss statement. The ESC consists of the Chief Executive Officer (CEO), the Chief Financial Officer (CFO), and the three Business Presidents., as well as a forecast for 2026. For the terminal value, a market growth of 2.25 % is assumed. The main assumptions used for cash flow projections are EBITDAEBITDAEarnings before interest, taxes, depreciation, and amortization. in percent of sales and sales growth. The assumptions regarding these two variables are based on Management’s past experience and future expectations of business performance. The pre-tax discount rates used are based on the Group’s weighted-average cost of capital. The assumed pre-tax discount rate was 12.66 % for all cash generating units (2021: 10.70 %).
For all CGUs, it was assumed that they achieve sales growth in line with or higher than market growth, based on the specific strategic plans for the respective CGUs. It was also assumed that the EBITDAEBITDAEarnings before interest, taxes, depreciation, and amortization. in percent of sales will improve over present performance as a result of the continuous growth and improvement measures implemented. The conclusion was that the net present value of the expected cash flows exceeds the carrying amount of the net assets allocated on a value-in-use basis of all CGU’s.
The estimated recoverable amount of the CGU Catalysts exceeds its carrying amount, including goodwill, by CHF 177 million. The recoverable amount would be equal to the carrying amount if the assumed average annual sales growth rate during the planning period were reduced by 1.5 %, or alternatively, if the operating margin was reduced by 1.7 % of sales.
7. Leases
in CHF m | 31.12.2022 | 31.12.2021 | ||
---|---|---|---|---|
Right-of-use assets - net book value | ||||
Leasehold land | 27 | 30 | ||
Buildings | 120 | 149 | ||
Machinery and equipment | 81 | 90 | ||
Furniture, vehicles, computer hardware | 18 | 24 | ||
Total | 246 | 293 | ||
Reclassified to held for sale (see note 25) | –6 | –12 | ||
Total as reported in the balance sheet | 240 | 281 | ||
Lease liabilities | ||||
Non-current lease liabilities | 199 | 238 | ||
Current lease liabilities | 46 | 51 | ||
Total | 245 | 289 | ||
Reclassified to held for sale (see note 25) | –6 | –7 | ||
Total as reported in the balance sheet | 239 | 282 |
Additions to the right-of-use assets during 2022 were CHF 19 million (2021: CHF 129 million).
Consolidated income statements include the following amounts relating to leases:
in CHF m | 2022 | 2021 | ||
---|---|---|---|---|
Depreciation expense | ||||
Leasehold land | –3 | –3 | ||
Buildings | –28 | –29 | ||
Machinery and equipment | –11 | –9 | ||
Furniture, vehicles, computer hardware | –12 | –13 | ||
Total depreciation | –54 | –54 | ||
Interest expense, included in finance costs | –10 | –11 | ||
Expense relating to short-term leases | –9 | –11 | ||
Expense relating to leases of low-value assets | –3 | –4 | ||
Total | –77 | –80 | ||
Thereof reported under discontinued operations | – | 1 | ||
Total continuing operations | –77 | –79 |
The total cash outflow for leases in 2022 was CHF 64 million (2021: CHF 70 million).
There are CHF 4 million of commitments for leases not commenced at year-end 2022 (2021: CHF 1 million).
Potential future cash outflows arising from extension options in the amount of CHF 67 million were not reflected in the measurement of lease liabilities on 31 December 2022 (2021: CHF 44 million).
8. Investments in associates and joint ventures
in CHF m | 2022 | 2021 | ||
---|---|---|---|---|
As per 1 January | 350 | 344 | ||
Change in the scope of consolidation | – | –14 | ||
Additions | 116 | – | ||
Disposals | –140 | – | ||
Share in profit | 41 | 69 | ||
Share in other comprehensive income of associates and joint ventures | 9 | 2 | ||
Dividends received | –40 | –44 | ||
Exchange rate differences | –9 | –7 | ||
At 31 December | 327 | 350 | ||
Thereof joint ventures | 17 | 120 | ||
Reclassified to held for sale (see note 25) | – | –139 | ||
Total as reported in balance sheet | 327 | 211 |
The key financial data of the Group’s principal associates is as follows:
Investments in associates:
Infraserv GmbH & Co. Höchst KG | Infraserv GmbH & Co. Gendorf KG | Infraserv GmbH & Co. Knapsack KG | Heubach Group | Others | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Germany | Germany | Germany | Luxembourg | |||||||||||||||||
in CHF m | 2022 | 2021 | 2022 | 2021 | 2022 | 2021 | 2022 | 2021 | 2022 | 2021 | ||||||||||
Summarized financial information | ||||||||||||||||||||
Interest held % | 33 % | 33 % | 50 % | 50 % | 21 % | 21 % | 20 % | – | – | – | ||||||||||
Revenue | 1 602 | 1 218 | 362 | 294 | 276 | 250 | 1 179 | – | 73 | 149 | ||||||||||
Total comprehensive income | 113 | 82 | 41 | 34 | 16 | 13 | –127 | – | 11 | 21 | ||||||||||
Net income | 91 | 78 | 33 | 33 | 16 | 13 | –127 | – | 11 | 21 | ||||||||||
Other comprehensive income | 22 | 4 | 8 | 1 | – | – | – | – | – | – | ||||||||||
Current assets | 310 | 351 | 96 | 106 | 69 | 78 | 655 | – | 41 | 94 | ||||||||||
Non-current assets | 965 | 930 | 184 | 193 | 117 | 119 | 783 | – | 8 | 23 | ||||||||||
Current liabilities | –225 | –311 | –71 | –78 | –40 | –73 | –279 | – | –14 | –40 | ||||||||||
Non-current liabilities | –719 | –687 | –73 | –90 | –63 | –41 | –702 | – | –4 | –3 | ||||||||||
Net assets | 331 | 283 | 136 | 131 | 83 | 83 | 457 | – | 31 | 74 | ||||||||||
Reconciliation of book value | ||||||||||||||||||||
Book value at the beginning of the period | 94 | 87 | 66 | 69 | 17 | 19 | – | – | 53 | 52 | ||||||||||
Additions | – | – | – | – | – | – | 116 | – | 0 | – | ||||||||||
Disposals | – | – | – | – | – | – | – | – | –33 | – | ||||||||||
Change in the scope of consolidation | – | – | – | – | – | – | – | – | – | –14 | ||||||||||
Share in profit for the period | 33 | 25 | 16 | 17 | 3 | 3 | –25 | – | 6 | 17 | ||||||||||
Share in other comprehensive income | 5 | 2 | 4 | – | – | – | – | – | – | – | ||||||||||
Dividends received | –16 | –16 | –15 | –17 | –2 | –3 | – | – | –3 | –6 | ||||||||||
Foreign exchange rate differences | –6 | –4 | –3 | –3 | –1 | –2 | – | – | 1 | 4 | ||||||||||
Book value at the end of the period | 110 | 94 | 68 | 66 | 17 | 17 | 91 | – | 24 | 53 | ||||||||||
Clariant's share in the book values at the end of the period | 110 | 94 | 68 | 66 | 17 | 17 | 91 | – | 24 | 53 | ||||||||||
Reclassified to held for sale (see note 25) | – | – | – | – | – | – | – | – | 32 |
The Infraserv companies were set up by the former Hoechst group to cater to the infrastructure needs of its subsidiaries in Germany prior to 1997.
On 3 January 2022, Clariant completed the sale of its PigmentsPigmentsPigments are substances used for coloring; they are used in a technical manner, for example in the manufacture of dyes, varnishes, and plastics. In 2020, Clariant launched the divestment process of its Pigments business, which was completed on 3 January 2022. business to a consortium of Heubach and SK Capital. On the same day, Clariant rolled over CHF 116 million to retain a 20 % stake in the new holding company, alongside Heubach and SK Capital. This combined business is a global PigmentsPigmentsPigments are substances used for coloring; they are used in a technical manner, for example in the manufacture of dyes, varnishes, and plastics. In 2020, Clariant launched the divestment process of its Pigments business, which was completed on 3 January 2022. player.
The shareholdings in associates summarized under »Others« concern mainly companies specializing in selling Clariant products. The disposals reported in 2022 are part of the sale of the PigmentsPigmentsPigments are substances used for coloring; they are used in a technical manner, for example in the manufacture of dyes, varnishes, and plastics. In 2020, Clariant launched the divestment process of its Pigments business, which was completed on 3 January 2022. business.
On 31 December 2022, accumulated unrecognized losses amounted to CHF 4 million (2021: CHF 4 million).
In 2022, an amount of CHF 2 million was received when the escrow account associate with the disposal of 25 % stake of GTC associates in the United States in 2019 was closed.
Investments in joint ventures:
Scientific Design Company Inc. | Global Amines group | |||||||
---|---|---|---|---|---|---|---|---|
USA | ||||||||
in CHF m | 2022 | 2021 | 2022 | 2021 | ||||
Summarized financial information | ||||||||
Interest held % | 50 % | 50 % | 50 % | 50 % | ||||
Revenue | – | 105 | 307 | 243 | ||||
Total comprehensive income | – | 14 | 9 | 14 | ||||
Net income | – | 14 | 16 | 14 | ||||
Other comprehensive income | – | – | –7 | – | ||||
Current assets | – | 108 | 123 | 101 | ||||
Non-current assets | – | 32 | 79 | 86 | ||||
Current liabilities | – | –34 | –113 | –101 | ||||
Non-current liabilities | – | –11 | –10 | –13 | ||||
Net assets | – | 95 | 79 | 73 | ||||
Reconciliation of book value | ||||||||
Book value beginning of period | 107 | 108 | 13 | 10 | ||||
Share in profit for the period | – | – | 8 | 7 | ||||
Disposals | –107 | – | – | – | ||||
Dividends received | – | – | –4 | –2 | ||||
Foreign exchange rate differences | – | –1 | – | –2 | ||||
Book value end of the period | – | 107 | 17 | 13 | ||||
Reclassified to held for sale (see note 25) | 107 | – | ||||||
Group's share in net assets at the end of the period | – | 48 | 40 | 36 | ||||
Fair value adjustment/goodwill | – | 66 | – | – | ||||
Impairment | – | – | –23 | –23 | ||||
Taxes, minorities, and other adjustments | – | – | – | – | ||||
Clariant's share in the book values at the end of the period | – | 114 | 17 | 13 |
Scientific Design Company Inc., headquartered in the United States, is a producer of ethylene and oxide catalysts and has around 140 employees. Co-owner is the Saudi Arabia-based Sabic Group. On 14th April 2022, Clariant sold its 50 % participation in this joint venture to the joint venture partner SABIC for a net consideration of CHF 129 million, realizing a gain of CHF 22 million.
Global Amines group is a joint venture of Clariant and Wilmar International Limited, a leading Asian agribusiness group headquartered in Singapore, and serves as a global platform for the production and sale of fatty amines and selected amine derivatives. It also has worldwide sales, distribution, and production facilities. The joint venture has existed since 26 October 2012 and is operated as part of the Business Unit ICS.
9. Financial assets
in CHF m | 2022 | 2021 | ||
---|---|---|---|---|
At 1 January | 198 | 202 | ||
Additions | 39 | 5 | ||
Fair value adjustment | –4 | 2 | ||
Repayments and disposals | – | –2 | ||
Exchange rate differences | –8 | –9 | ||
At 31 December | 225 | 198 |
Financial assets include loans to associates, joint ventures and a number of small-scale participations in companies, mostly in Germany and in Switzerland, engaged in activities closely related to those of Clariant.
On 1 December 2022, the final purchase price for the PigmentsPigmentsPigments are substances used for coloring; they are used in a technical manner, for example in the manufacture of dyes, varnishes, and plastics. In 2020, Clariant launched the divestment process of its Pigments business, which was completed on 3 January 2022. business was agreed upon between Clariant and SK Capital / Heubach. Clariant received a vendor loan note in the amount of CHF 55 million, falling due on 3 January 2029 at the latest. The discounted value of that vendor loan amounted to CHF 38 million at the end of 2022 and was recorded in the balance sheet.
Participations amounted to CHF 186 million in 2022 (CHF 197 million in 2021).
In 2021, Clariant acquired a 10 % stake in Aqdot Limited, which develops intelligent encapsulation solutions for the consumer, agrochemical, and household and personal care industries. The purchase price amounted to CHF 5 million.
While loans are carried at amortized cost, participations are valued at fair value through OCI using Level 3 methods.
The valuation of participations is based on multiples of projected earnings and discounted cash flows. The change in participation values was mainly driven by the fair value estimation performed in 2022 and resulted in a decrease of CHF 3 million, which was recognized in other comprehensive income.
The key unobservable inputs used in the fair value estimation of the most material participation, which constitutes 86.4 % of these shareholdings, are as follows: terminal growth rate of 1.5 %, sales growth rate of 1 %, long-term pretax operating margin of 16 %, and weighted-average cost of capital of 11.4 %. The sensitivity analysis shows that if the terminal growth rate had been higher/lower by 0.5 percentage points with all other variables held constant, the fair value would have been CHF 6 million higher/lower. If the sales growth rate had been higher/lower by 1 percentage point with all other variables held constant, the fair value would have been CHF 32 million higher/CHF 31 million lower. If the long-term pre-tax operating margin had been higher/lower by 1 percentage point with all other variables held constant, the fair value would have been CHF 10 million higher/lower. If the weighted-average cost of capital had been higher/lower by 0.5 percentage points with all other variables held constant, the fair value would have been CHF 8 million lower/CHF 9 million higher.
10. Taxes
in CHF m | 2022 | 2021 | ||
---|---|---|---|---|
Current income taxes | –88 | –119 | ||
Deferred income taxes | –14 | –18 | ||
Total taxes | –102 | –137 | ||
Thereof reported under discontinued operations | –5 | 35 | ||
Total continuing operations | –107 | –102 |
The main elements contributing to the difference between the Group’s overall expected tax expense/rate and the effective tax expense/rate are:
2022 | 2021 | |||||||
---|---|---|---|---|---|---|---|---|
in CHF m | in % | in CHF m | in % | |||||
Income before taxes from continuing operations | 6 | 394 | ||||||
Income before taxes from discontinued operations | 212 | 116 | ||||||
Income before taxes total | 218 | 510 | ||||||
Expected tax expense/rate 1 | –69 | 31.7 | –146 | 28.6 | ||||
Effect of taxes on items not tax-deductible | –57 | 26.1 | –27 | 5.3 | ||||
Effect of utilization and changes in recognition of tax losses and tax credits | –24 | 11.0 | 3 | –0.6 | ||||
Effect of tax losses and tax credits of current year not recognized | –43 | 19.7 | –24 | 4.7 | ||||
Effect of adjustments to taxes recognized in prior periods | 5 | –2.3 | 18 | –3.5 | ||||
Effect of tax-exempt income | 73 | –33.5 | 40 | –7.8 | ||||
Effect of other items | 13 | –6.0 | –1 | 0.2 | ||||
Effective tax expense/rate | –102 | 46.8 | –137 | 26.9 | ||||
Thereof reported under discontinued operations | –5 | –2.4 | 35 | 30.2 | ||||
Effective tax expense/rate continuing operations | –107 | 1 783.3 | –102 | 25.9 | ||||
1 Calculated based on the income before tax of each subsidiary (weighted average).
|
In 2022, the tax expense from continuing operations increased to CHF 107 million, compared to CHF 102 million in the prior-year. The effective tax rate for the period (continuing operations) was negatively impacted by non-deductible impairments and FX losses as well as by non-recognized deferred tax assets on operational losses. These effects were partially offset by the positive impacts coming from higher share of profit generated in low tax jurisdictions and from the tax free capital gain realized on the sale of the participation held in Scientific Design.
In December 2021, the Organization for Economic Co-operation and Development (OECD) released a draft legislative framework, followed by a detailed guidance released in March 2022, that is expected to be introduced by individual jurisdictions that signed the agreement to amend their local tax laws. Clariant is closely monitoring the progress of the legislative process in each jurisdiction the Group operates and is in process of assessing the potential impact of the new regulation.
The movement of the net deferred income tax balance is as follows:
in CHF m | PPE, RoU assets and intangible assets | Retirement benefit obligations/ assets | Tax losses and tax credits | Other liabilities and provisions | Total | Thereof offset within the same jurisdiction | Total | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Deferred tax assets at 31 December 2021 | 137 | 97 | 43 | 101 | 378 | –220 | 158 | |||||||
Deferred tax liabilities at 31 December 2021 | –210 | –1 | –33 | –244 | 220 | –24 | ||||||||
Net deferred tax balance at 1 January 2021 | –73 | 96 | 43 | 68 | 134 | – | 134 | |||||||
Charged/credited to income | –7 | –11 | –14 | 14 | –18 | |||||||||
Total charged/credited to income statement | –7 | –11 | –14 | 14 | –18 | |||||||||
Charged/credited to other comprehensive income | – | –7 | 1 | – | –7 | |||||||||
Effect of disposals | 1 | – | – | – | 1 | |||||||||
Effect of acquisitions | 9 | – | – | – | 9 | |||||||||
Reclassified to/from held for sale | 18 | – | – | – | 18 | |||||||||
Exchange rate differences | 1 | 6 | –4 | –7 | –4 | |||||||||
Net deferred tax balance at 31 December 2021 | –51 | 84 | 25 | 75 | 133 | –220 | 133 | |||||||
Deferred tax assets at 31 December 2021 | 155 | 87 | 25 | 114 | 381 | –218 | 163 | |||||||
Deferred tax liabilities at 31 December 2021 | –206 | –3 | – | –39 | –248 | 218 | –30 | |||||||
Net deferred tax balance at 1 January 2022 | –51 | 84 | 25 | 75 | 133 | – | 133 | |||||||
Charged/credited to income statement | 23 | –5 | –30 | –2 | –14 | |||||||||
Total charged/credited to income statement | 23 | –5 | –30 | –2 | –14 | |||||||||
Charged/credited to other comprehensive income | – | –23 | – | 1 | –22 | |||||||||
Exchange rate differences | –9 | 1 | 5 | –1 | –4 | |||||||||
Net deferred tax balance at 31 December 2022 | –37 | 57 | – | 73 | 93 | – | 93 | |||||||
Deferred tax assets at 31 December 2022 | 119 | 57 | – | 107 | 283 | –163 | 120 | |||||||
Deferred tax liabilities at 31 December 2022 | –156 | – | – | –34 | –190 | 163 | –27 | |||||||
Net deferred tax balance at 31 December 2022 | –37 | 57 | – | 73 | 93 | 0 | 93 |
Of the deferred tax assets capitalized on tax losses, CHF 7 million pertains to tax losses of the Indian subsidiaries (2021: CHF 6 million). Clariant considers it probable that these tax losses can be recovered.
Deferred income tax liabilities have not been established for withholding tax and other taxes that would be payable on the unremitted earnings of certain foreign subsidiaries, as such amounts are currently regarded as permanently reinvested. These unremitted earnings totaled CHF 2 022 million at the end of 2022 (2021: CHF 2 252 million).
The tax losses on which no deferred tax assets are recognized are reviewed for recoverability at each balance sheet date. The largest part of these tax losses arose in the US (with a tax rate of 24 %), in France (with a tax rate of 27 %), in Canada (with a tax rate of 25 %), in Romania (with a tax rate of 16 %) and in the Switzerland (with a tax rate of 14 %). At present their recoverability is not considered probable.
Tax losses on which no deferred tax assets were recognized are as follows:
in CHF m | 31.12.2022 | 31.12.2021 | ||
---|---|---|---|---|
Expiry by: | ||||
2022 | - | 10 | ||
2023 | 1 | 5 | ||
2024 | 2 | 3 | ||
2025 | 34 | 33 | ||
2026 | 27 | |||
after 2026 (2021: after 2025) | 462 | 532 | ||
Total | 526 | 583 |
Tax credits amounting to CHF 3 million were recognized in 2022 (2021: CHF 9 million). They expire in and after 2027.
Temporary differences on which no deferred tax was recognized amount to CHF 658 million in 2022 (2021: CHF 1 208 million).
11. Inventories
in CHF m | 31.12.2022 | 31.12.2021 | ||
---|---|---|---|---|
Raw material, consumables, work in progress | 363 | 394 | ||
Finished products | 452 | 531 | ||
Total | 815 | 925 | ||
Reclassified to held for sale (see note 25) | –19 | –234 | ||
Total as reported in the balance sheet | 796 | 691 |
in CHF m | 2022 | 2021 | ||
---|---|---|---|---|
Movements in write-downs of inventories | ||||
As per 1 January | –34 | –40 | ||
Additions | –20 | –17 | ||
Reversals | 12 | 22 | ||
Effect of disposals | 7 | – | ||
Exchange rate differences | 2 | 1 | ||
At 31 December | –33 | –34 | ||
Thereof reclassified to held for sale | – | –7 |
In 2022, an impairment of CHF 2 million was recorded on the inventories of the Ukraine entity (see note 27).
As of 31 December 2022 and 2021, no inventories were pledged as collateral for liabilities.
The cost for raw materials and consumables recognized as an expense and included in »costs of goods sold« amounted to CHF 2 328 million (2021: CHF 1 860 million) for continuing operations.
12. Trade receivables
in CHF m | 31.12.2022 | 31.12.2021 | ||
---|---|---|---|---|
Gross accounts receivable – trade | 709 | 860 | ||
Gross accounts receivable – associates and joint ventures | 26 | 26 | ||
Less: provision for doubtful accounts receivable | –10 | –9 | ||
Total trade receivables – net | 725 | 877 | ||
Reclassified to held for sale (see note 25) | – | –148 | ||
Total as reported in the balance sheet | 725 | 729 |
The following summarizes the movement in the provision for doubtful accounts receivable:
in CHF m | 2022 | 2021 | ||
---|---|---|---|---|
As per 1 January | –9 | –5 | ||
Charged to the income statement | –10 | –9 | ||
Amounts used | 2 | 2 | ||
Unused amounts reversed | 6 | 2 | ||
Exchange rate differences | 1 | 1 | ||
At 31 December | –10 | –9 |
There is no concentration of credit risk with respect to trade receivables, as the Group has a large number of internationally dispersed customers.
The maximum credit risk on trade receivables is equal to their carrying amount.
Collaterals are only required in rare cases (less than CHF 1 million in 2022 and 2021).
The loss allowance for trade receivables as of 31 December 2022 and 2021 was determined as follows:
in CHF m | Current | 30–60 days overdue | 61–90 days overdue | More than 90 days overdue | Individually impaired | Total | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
31 December 2022 | ||||||||||||
Expected loss rate (in %) | 1.13 | 5.88 | 6.53 | 6.76 | ||||||||
Gross carrying amount, trade receivables | 704 | 7 | 4 | 20 | – | 735 | ||||||
Loss allowance | 9 | – | – | 1 | – | 10 |
in CHF m | Current | 30–60 days overdue | 61–90 days overdue | More than 90 days overdue | Individually impaired | Total | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
31 December 2021 | ||||||||||||
Expected loss rate (in %) | 0.92 | 3.05 | 3.23 | 3.29 | ||||||||
Gross carrying amount, trade receivables | 847 | 18 | 6 | 15 | – | 886 | ||||||
Loss allowance | 8 | 1 | – | – | – | 9 |
The carrying amounts of the Group’s trade receivables are denominated in the following currencies:
in CHF m | 31.12.2022 | 31.12.2021 | ||
---|---|---|---|---|
EUR | 287 | 344 | ||
USD | 233 | 262 | ||
CNY | 36 | 54 | ||
BRL | 41 | 45 | ||
JPY | 20 | 29 | ||
INR | 42 | 67 | ||
Other | 66 | 76 | ||
Total trade receivables – net | 725 | 877 | ||
Reclassified to held for sale (see note 25) | – | –148 | ||
Total as reported in the balance sheet | 725 | 729 |
As of 31 December 2022, »total trade receivables – net« include an amount of CHF 60 million (2021: CHF 72 million) that was past due, but not impaired. These related to a number of customers for whom there is no recent history of default.
13. Other current assets
Other current assets include the following:
in CHF m | 31.12.2022 | 31.12.2021 | ||
---|---|---|---|---|
Other receivables | 246 | 271 | ||
Current financial assets | 40 | 49 | ||
Prepaid expenses and accrued income | 41 | 44 | ||
Total | 327 | 364 | ||
Reclassified to held for sale (see note 25) | – | –48 | ||
Total as reported in the balance sheet | 327 | 316 |
Other receivables include, among others, staff loans, deposits, advances, and VAT and sales tax receivables.
Other receivables are recognized at amortized cost in the balance sheet.
Current financial assets are mainly made up of notes receivable and short-term loans. These are classified as loans and receivables and recognized at amortized cost in the balance sheet.
The book value of current financial assets equals their fair value.
Other receivables and current financial assets are also subject to the impairment requirements of IFRSIFRSThe International Financial Reporting Standards (IFRS) are international accounting standards. 9. The identified impairment loss for other receivables was immaterial in 2022 and 2021.
Other receivables are denominated in the following currencies:
in CHF m | 31.12.2022 | 31.12.2021 | ||
---|---|---|---|---|
CHF | 15 | 12 | ||
EUR | 41 | 78 | ||
USD | 4 | 18 | ||
JPY | 3 | 5 | ||
BRL | 29 | 33 | ||
CNY | 18 | 24 | ||
INR | 31 | 36 | ||
Other | 105 | 65 | ||
Total | 246 | 271 | ||
Thereof reclassified to held for sale | – | 46 |
Current financial assets are denominated in the following currencies:
in CHF m | 31.12.2022 | 31.12.2021 | ||
---|---|---|---|---|
CHF | 22 | 32 | ||
USD | 2 | 1 | ||
CNY | 15 | 16 | ||
Other | 1 | – | ||
Total | 40 | 49 |
The maximum exposure to credit risk of other current assets at the reporting date is equal to their carrying amount.
14. Short-term deposits
Short-term deposits have an original maturity between 90 and 365 days.
They are denominated in the following currencies:
in CHF m | 31.12.2022 | 31.12.2021 | ||
---|---|---|---|---|
EUR | 191 | – | ||
CHF | 125 | – | ||
INR | 8 | 12 | ||
Total | 324 | 12 |
15. Cash and cash equivalents
in CHF m | 31.12.2022 | 31.12.2021 | ||
---|---|---|---|---|
Cash at bank and on hand | 364 | 398 | ||
Short-term bank deposits | 30 | 17 | ||
Total | 394 | 415 |
Cash and cash equivalents are denominated in the following currencies:
in CHF m | 31.12.2022 | 31.12.2021 | ||
---|---|---|---|---|
EUR | 84 | 18 | ||
USD | 89 | 149 | ||
CHF | 81 | 83 | ||
GBP | 9 | 23 | ||
CNY | 38 | 8 | ||
JPY | 13 | 20 | ||
INR | 32 | 42 | ||
BRL | 11 | 23 | ||
Other | 37 | 49 | ||
Total | 394 | 415 |
During 2022, there were short-term bank deposits in Swiss francs, in euro and in US dollars. In 2021, there were short-term bank deposits in Swiss francs and in US-dollars.
The effective average annual interest rate on short-term bank deposits in Swiss franc was -0.12 % (2021: -0.55 %); these deposits have an average maturity of 19 days (2021: 50 days).
The effective average annual interest rate on short-term bank deposits in euro was 1.30 % (2021: none in place); these deposits have an average maturity of 60 days (2021: none in place).
The effective average annual interest rate on short-term bank deposits in US-dollar was 3.03 % (2021: 0.31 %); these deposits have an average maturity of 27 days (2021: 60 days).
At the end of 2022, there were no short-term bank deposits denominated in currencies other than the euro. At the end of 2021, there were no material short-term bank deposits denominated in currencies other than in Brazilian real.
The maximum exposure to credit risk on cash and cash equivalents is equal to their book value.
16. Cash flow: Additional information
for the years ended 31 December 2022 and 2021 | Notes | 2022 | 2021 | |||
---|---|---|---|---|---|---|
Non-cash income and expenses | 116 | 373 | ||||
Depreciation of property, plant, and equipment and right-of-use assets | 5, 7 | 238 | 224 | |||
Impairment | 27 | 462 | 1 | |||
Amortization of intangible assets | 6 | 38 | 43 | |||
Impairment of working capital | 27 | 18 | ||||
Income from associates and joint ventures | 8 | –41 | –69 | |||
Tax expense | 10 | 102 | 137 | |||
Net financial income and costs | 28 | 46 | 46 | |||
Gain/loss from disposals not qualifying as discontinued operations | –22 | – | ||||
Gain on disposals of discontinued operations | 25 | –219 | – | |||
Other non-cash items | 10 | –9 | ||||
Total non-cash income and expenses | 641 | 391 | ||||
Changes in net working capital and provisions | ||||||
Changes in inventories | –179 | –226 | ||||
Changes in trade receivables | –40 | –191 | ||||
Changes in trade payables | 77 | 196 | ||||
Changes in other current assets and liabilities | –49 | –26 | ||||
Changes in provisions (excluding payments for restructuring) | 48 | –58 | ||||
Total changes in net working capital and provisions | –143 | –305 |
17. Changes in share capital and treasury shares and changes in non-controlling interests
Registered shares each with a par value of CHF 2.60 (2021: CHF 3.00) | Number of shares 2022 | Par value 2022 in CHF m | Number of shares 2021 | Par value 2021 in CHF m | ||||
---|---|---|---|---|---|---|---|---|
Share capital as per 1 January | 331 939 199 | 996 | 331 939 199 | 1 228 | ||||
Nominal value reduction | –133 | –232 | ||||||
Share capital at 31 December | 331 939 199 | 863 | 331 939 199 | 996 | ||||
Treasury shares | –2 922 398 | –8 | –2 822 712 | –8 | ||||
Outstanding share capital at 31 December | 329 016 801 | 855 | 329 116 487 | 988 |
2'022 | 2'021 | |||
---|---|---|---|---|
Treasury shares (number of shares) | ||||
Holdings as per 1 January | 2 822 712 | 2 385 509 | ||
Shares purchased at market value | 238 862 | 657 207 | ||
Shares purchased on exercise of put options | 200 000 | 200 000 | ||
Shares transferred to employees | –339 176 | –420 004 | ||
Holdings at 31 December | 2 922 398 | 2 822 712 |
All shares are duly authorized and fully paid in.
Dividends are paid out as and when declared equally on all shares, excluding treasury shares. The information concerning payments per share to the shareholders is disclosed in the notes to the financial statements of Clariant Ltd.
In accordance with Article 5 of the Company’s Articles of Incorporation, no limitations exist with regard to the registration of shares which are acquired in one’s own name and on one’s own account. Special rules exist for nominees.
In accordance with Article 13 of the company’s Articles of Incorporation, each share has the right to one vote.
Distribution from share capital to shareholders
On 24 June 2022 the Annual General Meeting of Clariant AG approved a distribution through capital reduction by way of a par value reduction of the par value from CHF 3.00 to CHF 2.60 per registered share. The payout reduced the share capital by CHF 133 million.
Significant shareholders of 3 % or more of total share capital
Based on the notifications received by Clariant and published by SIX Exchange Regulation, as at 31 December 2022, the following shareholders held more than 3 % of the voting rights in Clariant Ltd:
Shareholders | Voting rights | |
---|---|---|
SABIC International Holdings B.V., Sittard, The Netherlands, controlled by the Public Investment Fund of Saudi Arabia (PIF), Riyadh, Kingdom of Saudi Arabia | 31.50 % 1 | |
BlackRock Inc., New York, United States | 3.80 % | |
Blue Beteiligungsgesellschaft mbH, Am Holzmaierfeld, 82064 Strasslach-Dingharting, Germany, and Maple Beteiligungsgesellschaft mbH, Am Holzmaierfeld, 82057 Icking, Germany 2 | 3.49 % | |
1 SABIC acquired 24.99 % of the shares of Clariant Ltd on 17 September 2018, and increased its participation by 6.51 % to 31.5 % on 9 September 2020. SABIC has not changed its participation of 31.5 % since then. The difference between this figure (i.e. 31.5 %) and the 32.35 % stated for 2021 corresponded to the amount of treasury shares held by Clariant Ltd as of 31 December 2021, which have to be aggregated to the shares held by SABIC solely for regulatory disclosure purposes due to the Governance Agreement entered into by SABIC and Clariant on 17 September 2018. Said Governance Agreement expired at the Annual General Meeting dated 24 June 2022 and consequently the treasury shares of Clariant Ltd have not to be aggregated to the SABIC shares any longer.
|
||
2 According to a disclosure notification published on 18 December 2018, a group consisting of Konstantin Winterstein, 80333 Munich, Germany, and Elisabeth Prinzessin zu Sayn-Wittgenstein, 80333 Munich, Germany, was formed.
|
Disclosure notifications during the 2022 financial year reported to the Stock Exchange Disclosure Office pursuant to Art. 120 of the Financial Markets Infrastructure Act (FMIA) as well as further information in relation to disclosure notifications can be found on the SIX Swiss Exchange reporting platform: www.six-exchange-regulation.com/en/home/publications/significant-shareholders.html
On 31 December 2021, the following shareholders held a participation of 3 % or more of the total share capital: SABIC International Holdings B.V., Sittard, The Netherlands, controlled by the Public Investment Fund of Saudi Arabia (PIF), Riyadh, Kingdom of Saudi Arabia: 32.35 %; BlackRock Inc., New York, United States: 3.8 %; Blue Beteiligungsgesellschaft mbH, Am Holzmaierfeld, 82064 Strasslach-Dingharting (Germany), and Maple Beteiligungsgesellschaft mbH, 82057 Icking (Germany): 3.49 %; PSquared Master SICAV Ltd, on behalf of its subfund Valetta, Malta Leveraged Event Fund LP, Grand Cayman, Cayman Islands, controlled by Patrick Schmitz-Morkramer, Zurich, Switzerland, and Patrick Bierbaum, Zurich, Switzerland: 3.035 %.
On 31 December 2022, Clariant AG itself held 2 922 398 shares in treasury, corresponding to 0.88 % of the share capital.
Non-controlling interests
As at 31 December 2022, non-controlling interests reported are primarily made up of those of the four following companies, representing more than 90 % of the minority shares reported:
Süd-Chemie India Ltd (SCIL) reported sales in the amount of CHF 234 million in the reporting period and total assets of CHF 220 million as per 31 December 2022. As per 31 December 2022, total equity of Süd-Chemie India Ltd (SCIL) amounted to CHF 220 million. The non-controlling interests of 50 % of the shares outstanding are owned by private shareholders in India.
Clariant IGL Specialty Chemicals, acquired on 1 July 2021, reported sales in the amount of CHF 146 million in 2022 and total assets of CHF 136 million as of end of December 2022, thereof current assets of CHF 44 million and non-currents assets of CHF 92 million. Total liabilities amounted to CHF 54 million, thereof current liabilities of CHF 38 million and non-current liabilities of CHF 16 million. The total equity of IGL therefore amounted to CHF 82 million as of 31 December 2022. The non-controlling interests of 49 % of the shares outstanding are owned by the India-based IGL group.
Clariant Huajin Catalysts (Panjin) Ltd, reported sales in the amount of CHF 42 million in 2022 and total assets in the amount of CHF 59 million as of 31 December 2022. The non-controlling interests of 40 % of the shares outstanding are held by Northern Huajin Chemical Industry Group Co. Ltd.
Clariant Catalysts (Japan) K.K. reported sales in the amount of CHF 166 million in 2022 and CHF 77 million of total assets as of 31 December 2022. The non-controlling interests of 38.6 % of the shares outstanding are held by Nissan Chemicals Industries Ltd.
Clariant Chemicals (India) Ltd was sold in 2022 together with the Pigment business.
18. Non-current financial debts
in CHF m | Interest rate in % | Term | Notional amount | Net amount 31.12.2022 | Net amount 31.12.2021 | |||||
---|---|---|---|---|---|---|---|---|---|---|
Straight bond | 3.500 | 2012-2022 | 175 CHF m | – | 175 | |||||
Certificates of indebtedness | mixed | 2020-2022 | 115 EUR m | – | 118 | |||||
Certificates of indebtedness | mixed | 2015-2023 | 150 EUR m | 148 | 155 | |||||
Certificate of indebtedness | 6 m EURIBOR +1.1 | 2016-2023 | 13 EUR m | 13 | 13 | |||||
Certificate of indebtedness | 1.137 | 2016-2023 | 27 EUR m | 26 | 27 | |||||
Certificate of indebtedness | 1.501 | 2016-2023 | 73 EUR m | 72 | 76 | |||||
Straight bond | 2.125 | 2014-2024 | 160 CHF m | 160 | 160 | |||||
Certificate of indebtedness | 1.194 | 2018-2024 | 92 EUR m | 91 | 95 | |||||
Certificate of indebtedness | 1.548 | 2018-2025 | 102 EUR m | 101 | 106 | |||||
Certificate of indebtedness | 6 m EURIBOR +0.95 | 2018-2025 | 54 EUR m | 53 | 55 | |||||
Certificate of indebtedness | 2.010 | 2016-2026 | 15 EUR m | 14 | 15 | |||||
Straight bond | 1.125 | 2019-2026 | 200 CHF m | 200 | 200 | |||||
Straight bond (green bond) | 2.717 | 2022-2027 | 175 CHF m | 175 | – | |||||
Certificate of indebtedness | 2.087 | 2018-2028 | 17 EUR m | 17 | 18 | |||||
Total straight bonds and certificates of indebtedness | 1 070 | 1 213 | ||||||||
Liabilities to banks and other financial institutions | 59 | 38 | ||||||||
Subtotal | 1 129 | 1 251 | ||||||||
Less: current portion (see note 23) | –259 | –293 | ||||||||
Total | 870 | 958 | ||||||||
Breakdown by maturity | ||||||||||
2023 | – | 271 | ||||||||
2024 | 274 | 283 | ||||||||
2025 | 189 | 170 | ||||||||
2026 | 215 | |||||||||
after 2026 (2021: after 2025) | 192 | 234 | ||||||||
Total | 870 | 958 | ||||||||
Breakdown by currency | CHF | 559 | 561 | |||||||
EUR | 276 | 374 | ||||||||
Others | 35 | 23 | ||||||||
Total | 870 | 958 | ||||||||
Fair value comparison (including current portion) | ||||||||||
Straight bonds | 529 | 554 | ||||||||
Certificates of indebtedness | 535 | 678 | ||||||||
Others | 155 | 38 | ||||||||
Total | 1 219 | 1 270 |
In 2022, five certificates of indebtedness in the amount of EUR 263 million with maturity in 2023 were reclassified to current financial debt.
Certificates of indebtedness issued in 2020 totaling EUR 115 million were repaid in 2022. On 28 April 2022, before its maturity, one certificate was partially repaid (EUR 13 million); the remaining part (EUR 15 million) was repaid at maturity on 23 May 2022. On that same date, another certificate of indebtedness with a nominal value of EUR 87 million reached maturity and was repaid.
On 26 September 2022, a bond issued in 2012 in the amount of CHF 175 million reached maturity and was repaid and on that same date, a new green bond with a nominal value of CHF 175 million and maturity in 2027 was issued.
On 23 August 2021, two certificates of indebtedness issued in 2020 were repaid early (CHF 37 million, original maturity 2022; CHF 25 million, original maturity 2025).
On 22 November 2021, the certificate of indebtedness issued in 2020 with a notional amount of EUR 83 million was repaid early (original maturity 2025).
Valuation. Non-current financial debt is recognized initially at fair value, net of transaction costs incurred. Financial debt is subsequently stated at amortized cost. There are no long-term financial liabilities valued at fair value through profit or loss.
Fair values of straight bonds are determined by quoted market prices (Level 1 in the fair value hierarchy).
Certificates of indebtedness and other financial debts are recorded at notional amounts, which are a reasonable approximation of the fair values.
Covenants. For the covenants, please refer to note 3.1.3 Liquidity risk.
Exposure of the Group’s borrowings to interest rate changes
- Bonds: The interest rates of all bonds are fixed.
- Certificates of indebtedness: Most of the existing certificates of indebtedness have a fixed coupon.
- Liabilities to banks and other financial institutions: These mostly consist of bank loans mainly with fixed interest rates.
Collateral. In 2022 and 2021, no assets were pledged as collateral.
19. Reconciliation of net debt
in CHF m | 01.01.2022 | Effects of business acquisitions | Movements in cash flow | Exchange rate differences | Other non-cash movements | 31.12.2022 | Reclassified to held for sale (see note 25) | Total as reported in balance sheet | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash and cash equivalents | 415 | – | –10 | –11 | – | 394 | – | 394 | ||||||||
Short-term deposits | 12 | – | 313 | –1 | – | 324 | – | 324 | ||||||||
Financial instruments with positive fair values | 1 | – | 1 | – | – | 2 | – | 2 | ||||||||
Total cash and liquid investments | 428 | – | 304 | –12 | – | 720 | – | 720 | ||||||||
Non-current financial debt | –958 | – | –175 | 4 | 259 | –870 | – | –870 | ||||||||
Current financial debt | –709 | – | 573 | 40 | –259 | –355 | – | –355 | ||||||||
Lease liabilities | –282 | – | 64 | 10 | –37 | –245 | 6 | –239 | ||||||||
Borrowings and other financial liabilities | –1 949 | – | 462 | 54 | –37 | –1 470 | 6 | –1 464 | ||||||||
Net debt | –1 521 | – | 766 | 42 | –37 | –750 | 6 | –744 |
in CHF m | 01.01.2021 | Effects of business acquisitions | Movements in cash flow | Exchange rate differences | Other non-cash movements | 31.12.2021 | Reclassified to held for sale (see note 25) | Total as reported in balance sheet | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash and cash equivalents | 737 | – | –318 | –4 | – | 415 | – | 415 | ||||||||
Short-term deposits | 267 | – | –255 | – | 12 | – | 12 | |||||||||
Financial instruments with positive fair values | 5 | – | –4 | – | – | 1 | – | 1 | ||||||||
Total cash and liquid investments | 1 009 | – | –577 | –4 | – | 428 | – | 428 | ||||||||
Non-current financial debt | –1 424 | –24 | 150 | 47 | 293 | –958 | – | –958 | ||||||||
Current financial debt | –411 | – | 12 | –24 | –293 | –716 | 7 | –709 | ||||||||
Lease liabilities | –214 | – | 70 | 3 | –148 | –289 | 7 | –282 | ||||||||
Borrowings and other financial liabilities | –2 049 | –24 | 232 | 26 | –148 | –1 963 | 14 | –1 949 | ||||||||
Net debt | –1 040 | –24 | –345 | 22 | –148 | –1 535 | 14 | –1 521 |
20. Retirement benefit obligations
Apart from the legally required social security schemes, the Group has numerous independent retirement benefit plans. As a principle, assets are held externally. For certain Group companies, however, no independent assets exist for the retirement benefit and other non-current employee benefit obligations. In these cases, the related liability is included in the balance sheet as part of the non-current liabilities.
Defined-benefit post-employment plans. Defined-benefit pensions and termination plans cover the majority of the Group’s employees. Future obligations and the corresponding assets of those plans considered as defined-benefit plans under IAS 19 are reappraised annually and reassessed at least every three years by independent actuaries. Assets are valued at fair value.
Pension assets for funded defined-benefit pension plans are managed according to local rules and legislation in each country.
The actual asset allocation is determined by current and expected economic and market conditions and in consideration of specific asset class risks in the risk profile. For this purpose, Asset Liability Matching studies are conducted by third-party experts on a regular basis to ensure that investment strategies for pension assets are in line with the structure of the plan members of the pension plan concerned.
In all countries with funded defined-benefit plans, the body governing the investment policy is constituted in accordance with local legal requirements. To the extent legally permitted, Clariant Corporate exercises influence to ensure that the investment policy is set in a way to serve best the needs of the retirement benefit plan and its members.
The largest defined-benefit plans are operated in Switzerland, the United Kingdom, the United States, and Germany. These plans make up 95.1 % of the total defined-benefit obligation.
The most important German plan is unfunded and covers the supplementary pension liabilities for plan members whose salaries exceed the level of the German mandatory social security coverage. Contributions are made primarily by the employer and vary depending on the salary level of the plan members. Benefits are paid out as annual pensions amounting to 20 % of total contributions. Lump-sum payments to employees are possible to the extent of the voluntary contributions. For employees having joined or joining in 2011 and later, there exists a funded retirement benefit plan. Contributions are primarily paid into the plan by the employer and vary depending on the income of the individual plan member. Employees contribute to the plan up to 2 % of pensionable earnings on a voluntary basis, to which the employer contributes an equal amount on top of the regular contributions. Pensions paid by this plan are principally based on the return on plan assets (contributions paid in plus interest), apart from a minimal interest. In addition, there exists a smaller, similarly structured funded defined-benefit plan for former employees of the Süd-Chemie group, acquired in 2011. All other pension liabilities regarding German staff members are covered by a funded multi-employer plan, which is accounted for as a defined-contribution plan.
The defined-benefit obligation in the United Kingdom is a funded plan covering the retirement benefit liabilities of UK employees who joined the Company before 31 December 2001 and was closed to further accruals in April 2016. All staff members are now covered by a defined-contribution plan. The defined-benefit pension plan is fully funded according to legal requirements.
In the United States, Clariant operates a funded defined-benefit pension plan covering the pension liabilities of employees who joined the Company before 31 December 2000. Contributions are paid by the employer exclusively. Benefits are paid out as lifetime pensions determined on the basis of a final/career average calculation. Staff members who joined on 1 January 2001 or later are covered by a defined-contribution plan. For members of Management whose annual salaries exceed the amount of CHF 275 000, an additional pension scheme is in place in the form of an unfunded defined-benefit obligation, which covers the part exceeding this amount.
US employees transferred to Clariant with the Hoechst Specialty Chemicals business remain insured with Hoechst for their pension claims incurred prior to 30 June 1997.
In Switzerland, Clariant operates a funded defined-benefit pension plan that covers the pension liabilities of all employees of the Swiss Clariant companies up to a salary level of CHF 200 000.
Both the employer and the employees contribute to the plan, the employer paying two-thirds of the total contributions. The pension plan provides lifetime pensions determined based on cumulative savings of the individual plan member and converted into an annual pension at a fixed conversion rate. Lump-sum payments are possible at up to 100 percent of the total individual cumulative savings.
The Swiss retirement benefit plan is marked by a shrinking operating basis and, as a result, an increasing share of retired members.
For members of Management whose annual salaries exceed the amount of CHF 200 000, an additional pension scheme is in place in the form of a funded defined-benefit obligation. Any shortfalls in funded provisions for pension commitments to members of the Executive Leadership TeamExecutive Leadership TeamThe Executive Leadership Team (ELT) consists of the Executive Steering Committee (ESC) along with the Chief Human Resources Officer, the Chief Technology & Sustainability Officer, the Chief Corporate Development Officer, and the General Counsel. By bringing all key functions together, Clariant ensures fast decision-making while incorporating all internal stakeholders’ needs. The ELT supports the ESC by promoting dialogue among its members, exchange of information and enabling awareness of the Group’s environment. are accounted for as an unfunded defined-benefit obligation.
Mortality tables
The following mortality tables were used to determine the defined pension obligation of the most important pension plans:
- Switzerland: BVG 2020 generation table
- Germany: Richttafeln 2018G by Prof. Dr. Klaus Heubeck
- UK: SAPS S3 series amount tables (base table), CMI Model (2021) (future improvements)
- USA: Pri 2012 mortality table with projection scale, MP-2021
Post-employment medical benefits. The Group operates a number of post-employment medical benefit schemes in the United States and France. The method of accounting for the liabilities associated with these plans is largely equal to the one used for defined-benefit pension schemes. These plans are not externally funded, but are recognized as provisions in the balance sheets of the Group companies concerned.
Expenses for net benefits are recorded in the same line and function in which the personnel costs are recorded.
Changes in the present value of defined-benefit obligations:
in CHF m | Pension plans (funded and unfunded) | Post-employment medical benefits (unfunded) | ||||||
---|---|---|---|---|---|---|---|---|
2022 | 2021 | 2022 | 2021 | |||||
As per 1 January | 2 395 | 2 497 | 45 | 48 | ||||
Current service cost | 23 | 28 | – | – | ||||
Past service cost/gain including curtailments | 16 | 11 | – | – | ||||
Gain/loss on settlements | –1 | –2 | – | – | ||||
Interest costs on obligation | 24 | 22 | 1 | 1 | ||||
Contributions to plan by employees | 8 | 14 | – | – | ||||
Benefits paid out to personnel in reporting period | –122 | –134 | –3 | –3 | ||||
Remeasurements: | ||||||||
Actuarial gain/loss arising from changes in demographic assumptions | –2 | –39 | – | –1 | ||||
Actuarial gain/loss arising from changes in financial assumptions | –554 | –45 | –9 | –1 | ||||
Actuarial gain/loss due to experience adjustments | 77 | 57 | 2 | 1 | ||||
Liabilities acquired in a business combination | – | 1 | – | – | ||||
Effect of disposals | –92 | – | – | – | ||||
Changes in the scope of consolidation | –2 | – | – | – | ||||
Exchange rate differences | –47 | –15 | – | – | ||||
At 31 December | 1 723 | 2 395 | 36 | 45 |
Changes in the fair value of plan assets:
in CHF m | 2022 | 2021 | ||
---|---|---|---|---|
As per 1 January | 2 053 | 1 932 | ||
Interest income on plan assets | 18 | 15 | ||
Contributions to plan by employees | 8 | 15 | ||
Contributions to plan by employer | 17 | 37 | ||
Benefits paid out to personnel in reporting period | –99 | –109 | ||
Remeasurements: | ||||
Return on plan assets (excluding amount included in interest expense) | –355 | 152 | ||
Effect of disposals | –60 | – | ||
Exchange rate differences | –33 | 11 | ||
At 31 December | 1 549 | 2 053 |
As at 31 December 2022 and 2021, the pension plan assets did not include any directly held registered shares or bonds issued by Clariant Ltd.
The amounts recognized in the balance sheets are as follows:
defined-benefit pension plans | Post-employment medical benefits | Total | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
31.12.2022 | 31.12.2021 | 31.12.2022 | 31.12.2021 | 31.12.2022 | 31.12.2021 | |||||||
Present value of funded obligations | –1 278 | –1 815 | – | – | –1 278 | –1 815 | ||||||
Fair value of plan assets | 1 549 | 2 053 | – | – | 1 549 | 2 053 | ||||||
Overfunding/Deficit | 271 | 238 | – | – | 271 | 238 | ||||||
Present value of unfunded obligations | –445 | –580 | –36 | –45 | –481 | –625 | ||||||
Limitation on recognition of net asset 1 | –217 | –166 | – | – | –217 | –166 | ||||||
Net liabilities, total | –391 | –508 | –36 | –45 | –427 | –553 | ||||||
Reclassified to held for sale (see note 25) | – | 36 | – | – | – | 36 | ||||||
Net liabilities in the balance sheet | –391 | –472 | –36 | –45 | –427 | –517 | ||||||
1 Limitation on recognition of net asset pertain to Swiss pension plan
|
Thereof recognized in:
in CHF m | 31.12.2022 | 31.12.2021 | 31.12.2022 | 31.12.2021 | 31.12.2022 | 31.12.2021 | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Retirement benefit obligations | –452 | –585 | –36 | –45 | –488 | –630 | ||||||
Reclassified to held for sale (see note 25) | – | 37 | – | – | – | 37 | ||||||
Retirement benefit obligations in the balance sheet | –452 | –548 | –36 | –45 | –488 | –593 | ||||||
Prepaid pension assets | 61 | 77 | – | – | 61 | 77 | ||||||
Reclassified to held for sale (see note 25) | – | –1 | – | – | – | –1 | ||||||
Prepaid pension assets in the balance sheet | 61 | 76 | – | – | 61 | 76 | ||||||
Net liabilities in the balance sheet for defined-benefit plans | –391 | –472 | –36 | –45 | –427 | –517 |
The amounts recognized in the income statement and in other comprehensive income are as follows:
defined-benefit pension plans | Post-employment medical benefits | Total | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
2022 | 2021 | 2022 | 2021 | 2022 | 2021 | |||||||
Current service cost | –23 | –28 | – | – | –23 | –28 | ||||||
Net interest cost | –6 | –7 | –1 | –1 | –7 | –8 | ||||||
Past service cost/gain including curtailments | –16 | –11 | – | – | –16 | –11 | ||||||
Gain/loss on settlements | 1 | 2 | – | – | 1 | 2 | ||||||
Components of defined-benefit expense reported in the income statement | –44 | –44 | –1 | –1 | –45 | –45 | ||||||
in CHF m | ||||||||||||
Actuarial gain/loss arising from changes in demographic assumptions | 2 | 39 | – | 1 | 2 | 40 | ||||||
Actuarial gain/loss arising from changes in financial assumptions | 554 | 45 | 9 | 1 | 563 | 46 | ||||||
Actuarial gain/loss due to experience adjustments | –77 | –57 | –2 | –1 | –79 | –58 | ||||||
Return on plan assets (excluding amount included in net interest expense) | –355 | 152 | – | – | –355 | 152 | ||||||
Limitation on recognition of net asset | –58 | –166 | – | – | –58 | –166 | ||||||
Components of defined-benefit gain reported in other comprehensive income | 66 | 13 | 7 | 1 | 73 | 14 | ||||||
Total defined-benefit expense/gain | 22 | –31 | 6 | – | 28 | –31 |
The fair value of the plan assets is split into the major assets categories as follows:
in CHF m | 31.12.2022 | 31.12.2021 | ||
---|---|---|---|---|
Equities | 306 | 427 | ||
thereof based on quoted market prices | 304 | 423 | ||
Bonds | 493 | 614 | ||
thereof based on quoted market prices | 344 | 423 | ||
Cash | 63 | 82 | ||
thereof based on quoted market prices | 63 | 82 | ||
Property | 241 | 298 | ||
thereof based on quoted market prices | 156 | 215 | ||
Alternative investments | 446 | 632 | ||
thereof based on quoted market prices | 111 | 220 | ||
Total fair value of plan assets | 1 549 | 2 053 |
The principal actuarial assumptions at the balance sheet date in percent:
2022 in % | 2021 in % | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Group | Most important countries | Group | Most important countries | |||||||||||||||||||
Weighted average | Switzer-land | United Kingdom | United States | Germany | Weighted average | Switzer-land | United Kingdom | United States | Germany | |||||||||||||
Discount rate | 3.4 | 2.0 | 5.0 | 5.1 | 3.9 | 1.1 | 0.2 | 1.8 | 2.6 | 1.2 | ||||||||||||
Future salary increases | 2.0 | 2.0 | – | 3.2 | 2.5 | 1.7 | 1.5 | – | 3.5 | 2.5 | ||||||||||||
Long-term increase in healthcare costs | 6.1 | – | – | 7.1 | 0.0 | 5.1 | – | – | 6.0 | – | ||||||||||||
Current average life expectancy for a 65-year-old male | in years | 19 | 23 | 20 | 21 | 21 | 18 | 23 | 21 | 21 | 20 | |||||||||||
Current average life expectancy for a 65-year-old female | in years | 21 | 25 | 24 | 23 | 24 | 20 | 25 | 24 | 23 | 24 |
A one-percentage-point change in healthcare cost trend rates would have the following effects on the obligation for post-employment medical benefits:
2022 in CHF m | One percentage point increase | One percentage point decrease | ||
---|---|---|---|---|
Effect on the aggregate of the service cost and interest cost | 0 | 0 | ||
Effect on defined-benefit obligation | 3 | –2 |
2021 in CHF m | One percentage point increase | One percentage point decrease | ||
---|---|---|---|---|
Effect on the aggregate of the service cost and interest cost | 1 | –1 | ||
Effect on defined-benefit obligation | 4 | –3 |
A 25-basis-point change in the discount rate would have the following effects on the obligation for pension plans:
in CHF m | 25 basis point increase | 25 basis point decrease | ||||||
---|---|---|---|---|---|---|---|---|
2022 | 2021 | 2022 | 2021 | |||||
Effect on defined-benefit obligation | –48 | –81 | 49 | 86 |
If life expectancy increased by one year, the defined-benefit obligation would increase by CHF 83 million (2021: CHF 96 million).
Defined-contribution post-employment plans. In 2022, CHF 18 million was charged to the income statement as contributions to defined-contribution plans (2021: CHF 22 million).
In Germany, approximately 3400 Clariant employees are insured in a defined-benefit plan that is a multi-employer plan and as such is accounted for as a defined-contribution plan. The reason for this accounting practice is that the plan exposes the participating Clariant companies to actuarial risks associated with the current and former employees of other companies that are members of the same pension plan. There is no consistent or reliable basis for allocating the obligation, plan assets, and cost to individual companies participating in the plan.
Based on the statutory actuarial calculation of 2022, the pension fund’s obligations are fully funded. Also, for 2023, it is anticipated that the pension plan liabilities will be covered by the respective assets.
In the event that the multi-employer plan faces a situation where the pension plan liabilities exceed the assets, this can be remedied either by increasing the employer’s contributions to the pension plan or by reducing the benefits paid out to the entitled parties. If the benefits are reduced, this must be compensated for by the employer according to German legislation. If the pension plan is unwound, the remaining funds will be distributed among the plan members. In case there are no plan members left, the remaining funds would be transferred to social institutions. If Clariant withdraws from the pension fund, all rights and obligations of the employer against the pension plan will remain in force as long as the pension plan continues to render pension services to the Group’s plan members. Based on the number of plan members (active and passive), Clariant’s share in the pension plan amounts to approximately 6 %.
Clariant’s contribution to this pension plan amounted to CHF 13 million in 2022 (CHF 16 million in 2021) and is expected to be CHF 13 million in 2023.
The multi-employer plan originates in the pension plan scheme of the German companies of the former Hoechst Group, to which a part of the activities of Clariant pertained until 1997. Several of the companies that were formerly part of the Hoechst Group continue to participate in this multi-employer plan.
in CHF m | Pension plans | Post-employment medical benefits | ||||||
---|---|---|---|---|---|---|---|---|
2022 | 2021 | 2022 | 2021 | |||||
Clariant Group regular and supplemental contributions (employer's contributions): | ||||||||
Actual contributions in 2021 | – | 37 | – | – | ||||
Actual contributions in 2022 (2021: estimated) | 17 | 19 | – | – | ||||
Estimated contributions in 2023 | 15 | 19 | – | – | ||||
Estimated contributions in 2024 | 15 | 19 | – | – | ||||
Estimated contributions in 2025 | 15 | 19 | – | – | ||||
Estimated contributions in 2026 | 16 | 19 | – | – | ||||
Estimated contributions in 2027 | 16 | – | ||||||
Payments to beneficiaries: | ||||||||
Actual payments in 2021 | 0 | –134 | – | –3 | ||||
Actual payments in 2022 (2021: estimated) | –122 | –120 | –3 | –3 | ||||
Estimated payments in 2023 | –111 | –110 | –4 | –3 | ||||
Estimated payments in 2024 | –110 | –112 | –4 | –3 | ||||
Estimated payments in 2025 | –106 | –113 | –4 | –3 | ||||
Estimated payments in 2026 | –105 | –113 | –3 | –3 | ||||
Estimated payments in 2027 | –106 | –3 | ||||||
Allocation of defined-benefit obligation to plan members (in CHF m): | ||||||||
Active members | 368 | 605 | 7 | 10 | ||||
Deferred members | 168 | 317 | 2 | 5 | ||||
Retired members | 1 187 | 1 473 | 27 | 30 | ||||
Total funded and unfunded obligations at 31 December | 1 723 | 2 395 | 36 | 45 | ||||
Weighted average duration of the defined-benefit obligation at the end of the reporting period (in years): | ||||||||
At 31 December | 11.5 | 14.4 | 9.6 | 9.8 |
21. Movements in provisions
in CHF m | Environmental provisions | Personnel provisions | Restructuring provisions | Other provisions | Total provisions 2022 | Total provisions 2021 | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
As per 1 January | 117 | 109 | 67 | 82 | 375 | 441 | ||||||
Additions | 22 | 122 | 65 | 26 | 235 | 212 | ||||||
Effect of business combinations (see note 26) | – | – | – | 19 | 19 | – | ||||||
Amounts used | –11 | –109 | –32 | –20 | –172 | –201 | ||||||
Unused amounts reversed | –2 | –10 | –14 | –22 | –48 | –68 | ||||||
Changes due to the passage of time and changes in discount rates | –3 | – | – | – | –3 | 1 | ||||||
Exchange rate differences | –2 | –5 | –4 | –2 | –13 | –10 | ||||||
At 31 December | 121 | 107 | 82 | 83 | 393 | 375 | ||||||
Of which | ||||||||||||
– Current portion | 21 | 92 | 57 | 45 | 215 | 223 | ||||||
– Non-current portion | 100 | 15 | 25 | 38 | 178 | 152 | ||||||
Total provisions | 121 | 107 | 82 | 83 | 393 | 375 | ||||||
Expected outflow of resources | ||||||||||||
Within 1 year | 21 | 92 | 57 | 45 | 215 | 223 | ||||||
Between 1 and 3 years | 29 | 11 | 24 | 19 | 83 | 77 | ||||||
Between 3 and 5 years | 23 | 1 | 1 | 6 | 31 | 23 | ||||||
Over 5 years | 48 | 3 | – | 13 | 64 | 52 | ||||||
Total provisions | 121 | 107 | 82 | 83 | 393 | 375 |
Environmental provisions. Provisions for environmental liabilities are made when there is a legal or constructive obligation for the Group that will result in an outflow of economic resources. It is difficult to estimate the future action required by Clariant, as well as the associated costs, to correct the environmental effects of prior disposals or releases of chemical substances by Clariant or other parties pursuant to environmental laws and regulations.
The material components of the environmental provisions consist of the costs to clean and refurbish contaminated sites and to treat and contain contamination at sites where the environmental exposure is less severe. The Group’s future remediation expenses are affected by a number of uncertainties, which include, but are not limited to, the method and extent of remediation and the percentage of material attributable to Clariant at the remediation sites relative to that attributable to other parties.
The environmental provisions reported in the balance sheet concern a number of different obligations, mainly in Germany, Brazil, the United States, and Switzerland.
Provisions are made for remedial work when there is an obligation to remedy environmental damage, as well as for containment work when required by environmental regulations. All provisions relate to environmental liabilities arising in connection with activities that occurred prior to the date when Clariant took control of the relevant site. At each balance sheet date, Clariant critically reviews all provisions and makes adjustments when required.
Personnel provisions. Personnel provisions include holiday entitlements, compensated absences such as sabbatical leave, jubilee, annual leave or other long-service benefits, profit sharing, and bonuses. Such provisions are established in proportion to the services rendered by the employee concerned.
Restructuring provisions. Restructuring provisions are established when there is a legal or constructive obligation for the Group that will result in the outflow of economic resources. The term restructuring refers to the activities that have as a consequence staff redundancies and the shutdown of production lines or entire sites. When the Group has approved a formal plan and has either started to implement the plan or announced its main features to the parties concerned and to the public, a restructuring provision is created. The restructuring provisions at the end of 2022 concern headcount reductions in various countries, with the largest amounts incurred in Germany and Switzerland. For further information regarding restructuring measures, refer to note 27.
Other provisions. Additionally, other provisions include provisions for obligations relating to tax (other than income tax) and legal cases and other items in various countries for which the amount can be reliably estimated.
All non-current provisions are discounted to reflect the time value of money, when material. Discount rates reflect current market assessments of the time value of money and the risk specific to the provisions in the respective countries.
22. Trade payables and other liabilities
in CHF m | 31.12.2022 | 31.12.2021 | ||
---|---|---|---|---|
Trade payables | 560 | 688 | ||
Contract liabilities | 166 | 91 | ||
Payables to associates and joint ventures | 39 | 55 | ||
Accruals | 136 | 156 | ||
Other liabilities | 163 | 190 | ||
Total trade payables and other liabilities | 1 064 | 1 180 | ||
Reclassified to non-current liabilities | –55 | –58 | ||
Reclassified to held for sale (see note 25) | – | –137 | ||
Total as reported in the balance sheet | 1 009 | 985 |
The amount recognized for trade payables is equal to their fair value.
Contract liabilities are short-term and will be recognized as revenues in the next reporting period.
23. Current financial debts
in CHF m | 31.12.2022 | 31.12.2021 | ||
---|---|---|---|---|
Banks and other financial institutions | 96 | 423 | ||
Current portion of non-current financial debts (see note 18) | 259 | 293 | ||
Total | 355 | 716 | ||
Reclassified to held for sale (see note 25) | – | –7 | ||
Total current financial debts as reported in the balance sheet | 355 | 709 | ||
Breakdown by maturity: | ||||
in CHF m | 31.12.2022 | 31.12.2021 | ||
Up to three months after the balance sheet date | 81 | 364 | ||
Three to six months after the balance sheet date | 234 | 143 | ||
Six to twelve months after the balance sheet date | 40 | 209 | ||
Total | 355 | 716 | ||
Reclassified to held for sale (see note 25) | – | –7 | ||
Total current financial debts as reported in the balance sheet | 355 | 709 |
On 3 January 2022, a bridge loan in the amount of EUR 250 million was repaid.
As of the end of December 2022, five certificates of indebtedness in the amount of EUR 263 million with maturity in 2023 have been reclassified to current financial debt.
Certificates of indebtedness issued in 2020 totaling EUR 115 million were repaid in 2022. On 28 April 2022, before its maturity, one certificate was partially repaid (EUR 13 million); the remaining part (EUR 15 million) was repaid at maturity on 23 May 2022. On that same date, another certificate of indebtedness with a nominal value of EUR 87 million reached maturity and was repaid.
On 26 September 2022, a bond issued in 2012 in the amount of CHF 175 million reached maturity and was repaid. On that same date, a new green bond with a nominal value of CHF 175 million and maturity in 2027 was issued.
On 5 August 2021, certificates of indebtedness issued in 2016 in the amount of EUR 55 million (CHF 60 million) and USD 277 million (CHF 250 million) reached maturity and were repaid.
Current financial debt is recognized initially at fair value, net of transaction costs incurred. Financial debt is subsequently stated at amortized cost. Except for derivatives, there are no current financial liabilities valued at fair value through profit or loss.
The fair value of financial debt at banks and other financial institutions approximates its carrying amount due to the short-term nature of these instruments.
24. Segment information
The Business Unit PigmentsPigmentsPigments are substances used for coloring; they are used in a technical manner, for example in the manufacture of dyes, varnishes, and plastics. In 2020, Clariant launched the divestment process of its Pigments business, which was completed on 3 January 2022., which has been reported as “discontinued operations” in the financial report since 2019, was sold on 3 January 2022. See also note 25.
Following the portfolio reorganization that was executed over the past few years with the disposal of the disposal of the Business Units MasterbatchesMasterbatchesThese are plastic additives in the form of granules with dyestuffs or other additives used to dye or alter the properties of natural plastic. and PigmentsPigmentsPigments are substances used for coloring; they are used in a technical manner, for example in the manufacture of dyes, varnishes, and plastics. In 2020, Clariant launched the divestment process of its Pigments business, which was completed on 3 January 2022., Clariant has grouped its remaining activities into three business areas (reportable segments): Care Chemicals (BU ICS), Catalysis (BU Catalysts), Natural Resources (BU Oil & Mining Services, BU Functional Minerals and BU Additives).
Intersegment transactions are entered into under the normal circumstances, terms, and conditions that would also be available to unrelated third parties.
Segment assets consist of property, plant, and equipment, goodwill, intangible assets, inventories, receivables, and investments in associates. They exclude deferred tax assets, financial assets, and operating cash. Segment liabilities comprise trade payables. They exclude items such as tax liabilities, provisions, pension liabilities, and corporate borrowings. Capital expenditure comprises additions to property, plant, and equipment, and intangibles.
SEGMENTS
in CHF m | Care Chemicals | Catalysis | Natural Resources | Corporate | Total Group | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2022 | 2021 | 2022 | 2021 | 2022 | 2021 | 2022 | 2021 | 2022 | 2021 | |||||||||||
Segment sales | 2 107 | 1 716 | 989 | 907 | 2 115 | 1 790 | 0 | – | 5 211 | 4 413 | ||||||||||
Sales to other segments | –8 | –17 | 0 | – | –5 | –24 | 0 | – | –13 | –41 | ||||||||||
Total sales from continuing operations | 2 099 | 1 699 | 989 | 907 | 2 110 | 1 766 | 0 | 0 | 5 198 | 4 372 | ||||||||||
Operating expenses | –1 707 | –1 421 | –1 208 | –825 | –2 052 | –1 557 | –159 | –129 | –5 126 | –3 932 | ||||||||||
Thereof: | ||||||||||||||||||||
Income from associates and joint ventures | 25 | 34 | 0 | – | 28 | 8 | –12 | –1 | 41 | 41 | ||||||||||
Gain/loss from disposals not qualifying as discontinued operations | – | – | – | – | – | – | 22 | – | 22 | – | ||||||||||
Restructuring, impairment, and transaction-related costs | –4 | –15 | –230 | 2 | –243 | –3 | –90 | –37 | –567 | –53 | ||||||||||
Operating income | 392 | 278 | –219 | 82 | 58 | 209 | –159 | –129 | 72 | 440 | ||||||||||
Net financial expenses and taxes | –162 | –148 | ||||||||||||||||||
Net result from continuing operations | –90 | 292 | ||||||||||||||||||
Result from discontinued operations | 217 | 81 | ||||||||||||||||||
Net income | 127 | 373 | ||||||||||||||||||
Segment assets | 1 303 | 1 299 | 1 591 | 1 847 | 1 448 | 1 548 | 0 | – | 4 347 | 4 694 | ||||||||||
Segment liabilities | –202 | –239 | –280 | –192 | –246 | –259 | 0 | – | –728 | –690 | ||||||||||
Net operating assets | 1 101 | 1 060 | 1 311 | 1 655 | 1 202 | 1 289 | 0 | 0 | 3 619 | 4 004 | ||||||||||
Segment assets reported as assets held for sale | 33 | – | – | 107 | 16 | – | – | – | 49 | 107 | ||||||||||
Corporate assets reported as assets held for sale | – | – | – | – | – | – | 1 | 2 | 1 | 2 | ||||||||||
Segment assets of discontinued operations reported as assets held for sale | – | – | – | – | – | – | – | – | – | 719 | ||||||||||
Assets held for sale | 33 | 0 | 0 | 107 | 16 | 0 | 1 | 2 | 50 | 828 | ||||||||||
Segment liabilities of discontinued operations reported as liabilities associated with assets held for sale | – | – | – | – | – | – | – | – | – | –247 | ||||||||||
Segment liabilities reported as assets held for sale | –6 | –6 | – | |||||||||||||||||
Liabilities directly associated with assets held for sale | – | – | – | – | –6 | – | – | – | –6 | –247 | ||||||||||
Corporate assets without cash | 1 082 | 1 088 | 1 082 | 1 088 | ||||||||||||||||
Corporate liabilities without financial liabilities | –1 477 | –1 608 | –1 477 | –1 608 | ||||||||||||||||
Net debt (see note 19) | –744 | –1 521 | –744 | –1 521 | ||||||||||||||||
Total net assets | 1 134 | 1 060 | 1 311 | 1 762 | 1 212 | 1 289 | –1 138 | –2 039 | 2 524 | 2 544 | ||||||||||
Thereof: | ||||||||||||||||||||
Investments in PPE and intangibles for the period | 49 | 66 | 63 | 196 | 93 | 56 | 7 | 15 | 212 | 333 | ||||||||||
Investments in associates and joint ventures at the end of the period | 91 | 85 | 0 | – | 98 | 121 | 138 | 5 | 327 | 211 | ||||||||||
Reconciliation of key figures | ||||||||||||||||||||
Operating income | 392 | 278 | –219 | 82 | 58 | 209 | –159 | –129 | 72 | 440 | ||||||||||
Add: systematic depreciation of PPE | 55 | 57 | 69 | 50 | 48 | 49 | 12 | 14 | 184 | 170 | ||||||||||
Add: impairment | – | – | 225 | – | 237 | 1 | 0 | – | 462 | 1 | ||||||||||
Add: depreciation of RoU assets | 9 | 9 | 11 | 8 | 19 | 20 | 15 | 17 | 54 | 54 | ||||||||||
Add: amortization of intangible assets | 13 | 7 | 7 | 12 | 18 | 21 | 0 | 3 | 38 | 43 | ||||||||||
EBITDAEBITDAEarnings before interest, taxes, depreciation, and amortization. 1 | 469 | 351 | 93 | 152 | 380 | 300 | –132 | –95 | 810 | 708 | ||||||||||
Add: restructuring, impairment, and transaction-related costs | 4 | 15 | 230 | –2 | 243 | 3 | 90 | 37 | 567 | 53 | ||||||||||
Less: impairment | – | – | –225 | – | –237 | –1 | – | – | –462 | –1 | ||||||||||
Less: gain/loss from disposals not qualifying as discontinued operations | – | – | – | – | – | – | –22 | – | –22 | – | ||||||||||
Adjusted EBITDAEBITDAEarnings before interest, taxes, depreciation, and amortization. | 473 | 366 | 98 | 150 | 386 | 302 | –64 | –58 | 893 | 760 | ||||||||||
Operating income | 392 | 278 | –219 | 82 | 58 | 209 | –159 | –129 | 72 | 440 | ||||||||||
Add: restructuring, impairment and transaction-related costs | 4 | 15 | 230 | –2 | 243 | 3 | 90 | 37 | 567 | 53 | ||||||||||
Less: gain/loss from disposals not qualifying as discontinued operations | – | – | – | – | – | – | –22 | – | –22 | – | ||||||||||
Adjusted operating income | 396 | 293 | 11 | 80 | 301 | 212 | –91 | –92 | 617 | 493 | ||||||||||
1 EBITDAEBITDAEarnings before interest, taxes, depreciation, and amortization. is earnings before interest, tax, depreciation and amortization.
|
Reconciliation of segment assets to total assets
in CHF m | 31.12.2022 | 31.12.2021 | ||
---|---|---|---|---|
Segment assets | 4 347 | 4 694 | ||
Segment assets reported as assets held for sale | 49 | 107 | ||
Corporate assets reported as assets held for sale | 1 | 2 | ||
Segment assets of discontinued operations reported as assets held for sale | – | 719 | ||
Corporate assets without cash | 1 082 | 1 088 | ||
Cash and cash equivalents | 394 | 415 | ||
Short-term deposits | 324 | 12 | ||
Financial instruments with positive fair values | 2 | 1 | ||
Total Assets | 6 199 | 7 038 |
in CHF m | Sales 1 | Non-current assets 2 | ||||||
---|---|---|---|---|---|---|---|---|
2022 | 2021 | 31.12.2022 | 31.12.2021 | |||||
EMEA | 2 122 | 1 888 | 1 780 | 1 975 | ||||
of which Germany | 636 | 533 | 1 074 | 1 122 | ||||
of which Switzerland | 37 | 28 | 450 | 355 | ||||
of which MEA | 364 | 320 | 29 | 22 | ||||
North America | 931 | 692 | 719 | 903 | ||||
of which USA | 870 | 649 | 719 | 889 | ||||
Latin America | 631 | 487 | 157 | 171 | ||||
of which Brazil | 308 | 227 | 84 | 101 | ||||
Asia-Pacific | 1 514 | 1 305 | 682 | 711 | ||||
of which China | 572 | 479 | 312 | 291 | ||||
of which India | 310 | 262 | 208 | 232 | ||||
Total | 5 198 | 4 372 | 3 338 | 3 760 | ||||
1 Allocated by region of third-party sale's destination. Continuing operations
|
||||||||
2 Non-current assets excluding deferred tax assets and pension plan assets.
|
All of the Group’s segments generate their revenues to the largest extent from the sale of products. These come in such a great variety that a meaningful grouping below the segment information is not possible.
Revenue from services recognized in 2022 amounted to CHF 50 million (2021: CHF 48 million) and mostly were incurred in Business AreaBusiness AreaFor the financial reporting, Clariant grouped its businesses in three core Business Areas: Care Chemicals, Catalysis, and Natural Resources. As of 1 January 2023, the Group conducts its business through the three newly formed Business Units Care Chemicals, Catalysts, and Adsorbents & Additives and will report accordingly as of the first quarter of 2023. Natural Resources.
For a description of the business units see note 1.25.
25. Discontinued operations and assets held for sale
In 2019, Clariant announced its intention to sell the Business Units PigmentsPigmentsPigments are substances used for coloring; they are used in a technical manner, for example in the manufacture of dyes, varnishes, and plastics. In 2020, Clariant launched the divestment process of its Pigments business, which was completed on 3 January 2022.. As a result, the related activities were reclassified to discontinued operations in June 2019. Income and expenses of the activities concerned have been reclassified to «discontinued operations» in the consolidated income statement and the assets and liabilities pertaining to these activities have been reclassified to «Assets held for sale» and «Liabilities directly associated with assets held for sale» in the consolidated balance sheet, according to IFRSIFRSThe International Financial Reporting Standards (IFRS) are international accounting standards. 5, Non-current assets held for sale and discontinued operations.
On 3 January 2022, Clariant sold the Business Unit PigmentsPigmentsPigments are substances used for coloring; they are used in a technical manner, for example in the manufacture of dyes, varnishes, and plastics. In 2020, Clariant launched the divestment process of its Pigments business, which was completed on 3 January 2022. to a consortium composed of the US-based SK Capital Partners and the German Heubach Group. The total consideration of the sale, net of cash transferred, net of the 20 % rolled over into the newly created group, and net of the vendor loan, amounted to CHF 579 million. The after-tax gain amounted to CHF 210 million. See table below.
in CHF m | 2022 | |
---|---|---|
Total cash proceeds received as of 31 December 2022 | 614 | |
Less cash and cash equivalents transferred | –35 | |
Proceeds from the disposal of discontinued operations | 579 | |
Outstanding amounts | 38 | |
Equity investment | 116 | |
Total consideration for the sale | 733 | |
Net assets sold, including disposal-related expenses | –449 | |
Gain on the disposal from discontinued operations | 284 | |
Effect of the reclassification of foreign exchange differences on previously held net investments in foreign entities | –75 | |
Gain on the disposal from discontinued operations before taxes | 209 | |
Taxes (curent and deferred) | 1 | |
Gain on the disposal from discontinued operations after taxes | 210 |
For a description of the business units please refer to note 1.25.
Other assets held for sale
In April 2022, Clariant completed the divestment of its 50 % stake in the joint venture that owns Scientific Design Company. The total consideration for the sale amounted to CHF 129 million, and the gain realized on the transaction amounted to CHF 22 million. This investment in associate was reported under held for sale in 2021 for an amount of CHF 107 million.
In October 2022, Clariant entered into an agreement to divest its North America Land Oil business to Dorf Ketal, India. In accordance with IFRSIFRSThe International Financial Reporting Standards (IFRS) are international accounting standards. 5, the assets and liabilities of that business have been valued at their fair value less cost to sell and reclassified to held for sale in the financial report. They represent a net amount of CHF 11 million at the end of 2022. An impairment of CHF 233 million was recognized in the 2022 income statement
In August 2022, Clariant entered into an agreement to divest its Quats business to Global Amines Company, Singapore, a 50/50 joint venture owned by Clariant and Wilmar. According to IFRSIFRSThe International Financial Reporting Standards (IFRS) are international accounting standards. 5, the assets and liabilities of that business have been reclassified to Held for Sale in the financial report and represent an amount of CHF 33 million per end of 2022. The agreed sales price, subject to standard purchase price adjustment mechanism, is set at USD 113 million.
Clariant considers it highly probable that both the North America Land Oil business and the Quats business will be sold within the next twelve months.
Assets held for sale amounted to CHF 50 million as of 31 December 2022 and mainly related to the assets pertaining to the Quats business and to the North American Land Oil business expected to be sold in 2023 (2021: CHF 2 million) of which CHF 26 million of Property, Plant and Equipment, CHF 19 million of inventories and CHF 6 million of Right-of-Use assets and the associated liabilities of a similar amount. Intangibles reclassified to other assets held for sale were fully depreciated.
DISCONTINUED OPERATIONS
in CHF m | Plastics & Coatings (discontinued) 1 | Corporate | Total discontinued operations | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
2022 | 2021 | 2022 | 2021 | 2022 | 2021 | |||||||
Sales | – | 912 | – | – | – | 912 | ||||||
Operating expenses | –10 | –802 | –6 | –21 | –16 | –823 | ||||||
Income from associates and joint ventures | – | 28 | – | – | – | 28 | ||||||
Restructuring (see note 27) | – | 2 | 10 | –5 | 10 | –3 | ||||||
Operating result | –10 | 140 | 4 | –26 | –6 | 114 | ||||||
Financial result | – | –1 | –1 | 2 | ||||||||
Result from discontinued operations before taxes | –10 | 3 | –7 | 116 | ||||||||
Taxes | – | 4 | 4 | –35 | ||||||||
Result from discontinued operations after taxes | –10 | 7 | –3 | 81 | ||||||||
Gain on the disposal of discontinued operations | 219 | – | 219 | – | ||||||||
Taxes (current and deferred) | 1 | – | 1 | – | ||||||||
Net result from discontinued operations | 210 | 7 | 217 | 81 | ||||||||
Currency translation differences of discontinued operations | 76 | –9 | ||||||||||
Other items | – | 4 | ||||||||||
Other comprehensive income/loss from discontinued operations | – | – | – | – | 76 | –5 | ||||||
Operating cash flows | – | –17 | – | –9 | – | –26 | ||||||
thereof: payments for restructuring | – | –9 | – | – | – | –9 | ||||||
Investing cash flows | – | –27 | – | – | – | –27 | ||||||
Total cash flow | – | –44 | – | –9 | – | –53 | ||||||
Cash flowCash flowEconomic indicator representing the operational net inflow of cash and cash equivalents during a given period. from disposals: | ||||||||||||
Gross proceeds | 768 | – | – | – | 768 | – | ||||||
Less cash and cash equivalents transferred | –35 | – | – | – | –35 | – | ||||||
Less equity investment | –116 | – | – | –116 | ||||||||
Less outstanding amounts | –38 | – | – | – | –38 | – | ||||||
Net proceeds from disposal | 579 | 0 | – | – | 579 | 0 | ||||||
Net assets held for sale: | ||||||||||||
Property, plant, and equipment | – | 192 | – | – | – | 192 | ||||||
Right-of-use assets | – | 12 | – | – | – | 12 | ||||||
Intangible assets | – | 30 | – | – | – | 30 | ||||||
Investments in associates and joint ventures | – | 32 | – | – | – | 32 | ||||||
Deferred and income tax assets | – | 22 | – | – | – | 22 | ||||||
Prepaid pension assets | – | 1 | – | – | – | 1 | ||||||
Inventories | – | 234 | – | – | – | 234 | ||||||
Trade receivables | – | 148 | – | – | – | 148 | ||||||
Other current assets | – | 48 | – | – | – | 48 | ||||||
Total assets held for sale | – | 719 | – | – | – | 719 | ||||||
Trade payables and other liabilities | – | –137 | – | – | – | –137 | ||||||
Retirement benefit obligations | – | –37 | – | – | – | –37 | ||||||
Provisions | – | –59 | – | – | – | –59 | ||||||
Lease liabilities | – | –7 | – | – | – | –7 | ||||||
Current financial debts | – | –7 | – | – | – | –7 | ||||||
Total liabilities directly associated with assets held for sale | – | –247 | – | – | – | –247 | ||||||
Total net assets held for sale | – | 472 | – | – | – | 472 | ||||||
1 Including the business unit PigmentsPigmentsPigments are substances used for coloring; they are used in a technical manner, for example in the manufacture of dyes, varnishes, and plastics. In 2020, Clariant launched the divestment process of its Pigments business, which was completed on 3 January 2022. for 12 months in 2021.
|
26. Acquisitions
US attapulgite business assets
On 31 October 2022, Clariant acquired from BASF its US-based attapulgite business assets by way of an asset deal for a preliminary consideration of USD 60 million. This acquisition pertains to the Business Unit Functional Minerals.
The provisional fair values of the identified assets and liabilities acquired and the resulting preliminary goodwill presented are as follows:
in CHF m | 2022 | |
---|---|---|
Total consideration for purchase | 60 | |
Recognized amounts of identifiable assets and liabilities assumed: | ||
Property plant and equipment | 63 | |
Intangible assets | 1 | |
Inventories | 14 | |
Provisions | –19 | |
Fair value of net assets acquired (preliminary) | 59 | |
Goodwill (preliminary) | 1 |
For this transaction, acquisition related costs of less than CHF 4 million, comprising M&A, legal costs and consulting, were recognized in Selling, general and administrative costs in 2022.
From the acquisition date up to the end of the year 2022, Clariant Corporation reported net sales of CHF 5 million and an operating result of CHF 0.5 million.
If the acquisition had occurred on 1 January 2022, estimated Group sales would have been CHF 27 million higher and the estimated operating result would have been CHF 2.5 million higher.
Beraca Ingredientes Naturais S.A.
On 25 October 2021 Clariant acquired the remaining 70 % of the shares of the Brazilian Personal Care company Beraca Ingredientes Naturais S.A. from the company’s founder-owners. The company is one of the foremost producers of natural ingredients for the Personal Care industry and is based in the Amazonas region. This acquisition pertains to the Business Unit Industrial & Consumer Care Services (ICS).
Clariant has been holding 30 % of the shares since 2015 and is now a 100 % owner. The shareholding was previously accounted for at equity and the transaction is treated as a step acquisition. Since the acquisition date, Beraca Ingredientes Naturais S.A. has been fully consolidated in Clariant’s financial statements. The summary of the financial impact of consolidating the company in the accounts at the acquisition date, using the fair values of identified assets and liabilities, is as reported below.
As part of the accounting for the business combination the 30 % shareholding previously held was revalued to fair value, which resulted in a one-time gain of CHF 9 million, recorded in Selling, general and administrative costs in the 2021 income statement.
Goodwill incurred in the acquisition refers to expected cost and supply chain synergies and better market access and remained unchanged.
The acquired intangible assets comprise mainly trademarks and developed technology.
in CHF m | 2021 | |
---|---|---|
Cash consideration of the acquisition in 2021 | 33 | |
Less cash and cash equivalents received | –2 | |
Total cash outflow for the acquisition in 2021 | 31 | |
Fair value of shareholdings previously owned | 13 | |
Total consideration for purchase | 44 | |
Recognized amounts of identifiable assets and liabilities assumed: | ||
Property plant, and equipment | 2 | |
Intangible assets | 12 | |
Inventories | 3 | |
Receivables | 5 | |
Other assets and liabilities | –3 | |
Fair value of net assets acquired | 19 | |
Goodwill | 25 |
For this acquisition, costs of less than CHF 1 million, comprising M&A, legal costs and tax advisory and consulting charges, were recognized in »Selling, general and administrative costs« in 2021.
From the acquisition date up to the end of the year 2021, Beraca Ingredientes Naturais S.A. reported net sales of CHF 3 million and an operating loss of CHF 1 million, including CHF 1 million of depreciation and amortization.
If the acquisition had occurred on 1 January 2021, the 2021 Group sales would have been CHF 12 million higher, and the 2021 operating result would have been CHF 6 million higher.
Joint venture Clariant IGL Specialty Chemicals Private Ltd
On 1 July 2021, Clariant and India Glycos Ltd (IGL) established a joint venture for ethylene oxide derivatives from renewable sources, Clariant contributing 51 % to the joint venture and IGL 49 %. As Clariant will exercise control over the joint venture, it is consolidated in Clariant’s financial accounts and accounted for as a business combination.
The joint venture is a combination of IGL’s business with bio-ethylene oxide derivatives from renewable sources and Clariant’s ICS activities in India, Sri Lanka, Bangladesh, and Nepal. It comprises a multipurpose plant in Kashipur, India including an alkoxylation plant. This acquisition pertains to the Business Unit Industrial & Consumer Care Services (ICS). Since the initiation of the joint venture, Clariant IGL SC is fully consolidated in Clariant’s financial statements. The summary of the financial impact of consolidating the joint venture in the accounts at the acquisition date, using the fair values of identified assets and liabilities is as reported below.
The acquired intangible assets comprise mainly customer relationships and vendor contracts.
in CHF m | 2021 | |
---|---|---|
Total cash outflow for the acquisition in 2021 | 58 | |
Total consideration for purchase | 58 | |
Recognized amounts of identifiable assets and liabilities assumed: | ||
Property plant and equipment | 47 | |
Intangible assets | 19 | |
Deferred tax assets | 9 | |
Inventories | 9 | |
Receivables | 10 | |
Financial debt | –23 | |
Pension plan liabilities | –1 | |
Other assets and liabilities | –1 | |
Fair value of net assets acquired | 69 | |
Non-controlling interests | –46 | |
Goodwill | 35 |
For this transaction, acquisition-related costs of less than CHF 1 million, comprising M&A, legal costs, and consulting, were recognized in Selling, general and administrative costs in 2021. Goodwill incurred in the acquisition referred to better access to important materials, in addition to expansion of the product portfolio and business know-how. Goodwill remained unchanged.
From the acquisition date up to the end of the year 2021, Clariant IGL Specialty Chemicals Inc. reported net sales of CHF 71 million and an operating result of CHF 9 million, including CHF 2 million of depreciation and amortization. This result includes the above-mentioned items of a one-time nature, which were incurred in connection with the takeover by Clariant. If the acquisition had occurred on 1 January 2021, the 2021 Group sales would have been CHF 54 million higher, and the 2021 operating result would have been CHF 8 million higher.
27. Restructuring, impairment, and transaction-related costs
in CHF m | 2022 | 2021 | ||
---|---|---|---|---|
Restructuring income/expenses | –51 | 1 | ||
Payments for restructuring | –32 | –38 | ||
Impairment loss | –462 | –1 | ||
thereof charged to inventories (see note 11) | –2 | – | ||
thereof charged to PPE (see note 5) | –236 | –1 | ||
thereof charged to intangible assets (see note 6) | –224 | – | ||
Transaction-related and other exceptional items | –67 | –77 | ||
Total restructuring, impairment, transaction-related and other exceptional items | –580 | –77 | ||
thereof reported under discontinued operations | –13 | –24 | ||
Total continuing operations | –567 | –53 |
In order to increase profitability over a sustained period, Clariant implements measures designed to improve the Group’s performance. The aim of these efforts is to increase the Group’s operating result and to reduce net working capital. The changes made to the processes and structures result in a reduction of headcount across the Group.
Restructuring. In 2022, Clariant recorded an expense from the creation and reversal of restructuring provisions in the amount of CHF 51 million (2021: income CHF 1 million).
Clariant reports in Continuing Operations a net increase in restructuring provisions in the amount of CHF 61 million in 2022, compared to an income of CHF 4 million in 2021 from two main initiatives. In June 2022, Clariant announced changes to its leadership and organizational structure as part of the Company’s ongoing initiatives to implement its purpose-led strategy and cultural transformation. The implementation of this new operating model resulted in total restructuring charges of CHF 49 million in 2022.
Additional measures were initiated in the global functions to further increase efficiency in service delivery by focusing on customer needs as well as centralization and automation of processes. Restructuring provisions of CHF 12 million were booked for these efficiency initiatives.
In addition in Discontinued Operations, an income from the change in restructuring provisions in the amount of CHF 10 million in 2022 was recorded, compared to an expense of CHF 3 million in 2021 for the rightsizing program.
Impairment. The impairment losses recorded in 2022 concerned mainly the North America Land Oil business (CHF 233 million), the Podari bio-ethanol plant (CHF 220 million) and the Ukraine assets (CHF 5 million). The ones recognized in 2021 relate mainly to properties, plants and equipment in the US, China and Italy.
Transaction-related and other exceptional items comprise expenses incurred in connection with the acquisition or disposal projects and corporate initiatives.
The total amount pertaining to continuing operations, CHF 567 million of restructuring, impairment, transaction-related costs, and other items (2021: CHF 53 million) is reported in the income statement from continuing operations as follows: CHF 468 million in cost of goods sold (2021: CHF 7 million), CHF 89 million in selling, general and administrative costs (2021: CHF 47 million), and CHF 10 million in Research & Development costs (2021: income of CHF 1 million).
28. Finance income and costs
Finance income
in CHF m | 2022 | 2021 | ||
---|---|---|---|---|
Interest income | 9 | 11 | ||
thereof interest on loans, receivables and deposits | 9 | 11 | ||
Other financial income | 9 | 13 | ||
Total finance income | 18 | 24 |
Finance costs
in CHF m | 2022 | 2021 | ||
---|---|---|---|---|
Interest expense | –55 | –62 | ||
thereof effect of discounting of non-current provisions | –2 | –3 | ||
thereof net interest component of pension provisions | –7 | –8 | ||
thereof interest on lease liabilities | –11 | –11 | ||
Other financial expenses | –9 | –8 | ||
Total finance costs before currency result | –64 | –70 | ||
Currency result, net | –21 | 2 | ||
Total finance costs | –85 | –68 | ||
thereof reported under discontinued operations (see note 25) | –1 | 2 | ||
Total continuing operations | –84 | –70 |
Other financial expenses include bank charges and miscellaneous financial expenses.
In 2022 and 2021, no foreign exchange gains pertaining to the ineffective part of hedges on net investments were recognized in the income statement.
Interest expense, other than the effect of discounting non-current provisions and the interest component of pension provisions, pertains to financial debts measured at amortized costs.
Interest costs capitalized on qualifying assets for 2022 were CHF 2 million (2021: CHF 3 million).
29. Earnings per share (EPS)
Earnings per share are calculated by dividing the Group net income by the average number of outstanding shares (issued shares less treasury shares).
2022 | 2021 | |||
---|---|---|---|---|
Net income attributable to shareholders of Clariant Ltd, undiluted and diluted in CHF m | ||||
Continuing operations | –133 | 267 | ||
Discontinued operations | 217 | 77 | ||
Total | 84 | 344 | ||
Weighted average number of shares outstanding | ||||
As per 1 January | 329 336 789 | 329 517 644 | ||
Effect of transactions with treasury shares on weighted average number of shares outstanding | –172 203 | –180 855 | ||
Weighted average number of shares outstanding at 31 December | 329 164 586 | 329 336 789 | ||
Adjustment for granted Clariant shares | 1 606 420 | 2 053 495 | ||
Weighted average diluted number of shares outstanding at 31 December | 330 771 006 | 331 390 284 | ||
Basic earnings per share attributable to shareholders of Clariant Ltd (CHF/share) | ||||
Continuing operations | –0.40 | 0.81 | ||
Discontinued operations | 0.66 | 0.23 | ||
Total | 0.26 | 1.04 | ||
Diluted earnings per share attributable to shareholders of Clariant Ltd (CHF/share) | ||||
Continuing operations | –0.40 | 0.81 | ||
Discontinued operations | 0.66 | 0.23 | ||
Total | 0.26 | 1.04 |
The dilution effect is triggered by the effect of Clariant shares that have been granted as part of the share-based payment plan but have not yet vested. To calculate this dilutive potential, it is assumed that they vested on 1 January of the respective period. The effect of the services still to be rendered during the vesting period is taken into consideration.
Diluted earnings per share are calculated by adjusting the weighted-average number of ordinary shares outstanding to assume conversion of all dilutive potential ordinary shares.
In 2022, Clariant made a cash distribution of CHF 0.40 per share to its shareholders out of the share capital, reducing the nominal value from CHF 3.00 to CHF 2.60 per share (see note 17).
30. Derivative financial instruments
Risk management (hedging) instruments and off-balance sheet risks. Clariant uses forward foreign exchange rate and option contracts, currency options as well as other financial instruments to hedge the Group’s risk exposure to volatility in interest rates, currencies, and prices and to manage the return on cash and cash equivalents. Risk exposures from existing assets and liabilities as well as anticipated transactions are managed centrally.
Interest rate management. It is the Group’s policy to manage the costs of interest using fixed- and variable-rate debt and interest-related derivatives.
Foreign exchange management. To manage the exposure to the fluctuations in foreign currency exchange rates, the Group follows a strategy of hedging both balance sheet and revenue risk, partially through the use of forward contracts and currency swaps in various currencies. In order to contain costs, the Group does not hedge the entire exposure.
The following tables show the contract or underlying principal amounts and the respective fair value of derivative financial instruments by type at year-end.
The contract or underlying principal amounts indicate the volume of business outstanding at the balance sheet date and do not represent the amount at risk.
Derivative Financial instruments
in CHF m | Contract or underlying principal amount | Positive fair values | Negative fair values | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
31.12.2022 | 31.12.2021 | 31.12.2022 | 31.12.2021 | 31.12.2022 | 31.12.2021 | |||||||
Interest rate-related instruments | ||||||||||||
Interest rate swaps | – | – | – | – | – | |||||||
Cross-Currency Swaps | 150 | 364 | – | – | –25 | –22 | ||||||
Currency-related instruments | ||||||||||||
Forward foreign exchange rate contracts | 66 | 413 | 2 | 1 | – | – | ||||||
Total derivative financial instruments | 216 | 777 | 2 | 1 | –25 | –22 |
The fair value of these derivative financial instruments is recorded in other current assets in the balance sheet in the case of a positive value or in current financial debts in the case of a negative value and if the instruments expire within the next twelve months.
If the remaining lifetime exceeds twelve months, the value is recorded in financial assets in case it is positive and in non-current financial debts in case it is negative.
Derivative financial instruments by maturity
in CHF m | 31.12.2022 | 31.12.2021 | ||
---|---|---|---|---|
Breakdown by maturity: | ||||
Up to one month after the balance sheet date | 24 | 32 | ||
More than one and up to three months after the balance sheet date | 42 | 263 | ||
More than three and up to twelve months after the balance sheet date | – | 324 | ||
More than one and up to five years after the balance sheet date | 150 | 158 | ||
Total derivative financial instruments | 216 | 777 |
Derivative Financial instruments by currency
in CHF m | 31.12.2022 | 31.12.2021 | ||
---|---|---|---|---|
USD | 58 | 278 | ||
EUR | 150 | 493 | ||
JPY | 6 | 4 | ||
Others | 2 | 2 | ||
Total derivative financial instruments | 216 | 777 |
Financial instruments effective for hedge-accounting purposes
in CHF m | 31.12.2022 | 31.12.2021 | ||
---|---|---|---|---|
Contracts with negative fair values | –25 | –22 | ||
Cross-Currency Swaps | –8 | –5 | ||
Notional amount (EUR) | 50 | 50 | ||
Maturity date | 25.03.2024 | 25.03.2024 | ||
Hedge ratio | 1:1 | 1:1 | ||
Change in fair value since 1 January | –3 | –3 | ||
Change in fair value of hedged item | 3 | 3 | ||
Cross-Currency Swaps | –17 | –9 | ||
Notional amount (EUR) | 103 | 103 | ||
Maturity date | 25.09.2025 | 25.09.2025 | ||
Hedge ratio | 1:1 | 1:1 | ||
Change in fair value since 1 January | –8 | –6 | ||
Change in fair value of hedged item | 8 | 6 | ||
Cross-Currency Swaps | – | –8 | ||
Notional amount (EUR) | – | 200 | ||
Maturity date | – | 29.07.2022 | ||
Hedge ratio | – | 1:1 | ||
Change in fair value since 1 January | – | –8 | ||
Change in fair value of hedged item | – | 8 | ||
Notional amount of hedges of net investments in foreign entities: | ||||
Contracts with positive values | 236 | 521 | ||
Borrowings denominated in foreign currencies | –236 | –521 | ||
EUR amount | –236 | –521 | ||
Hedge ratio | 1:1 | 1:1 |
Since 2015, Clariant issued various certificates of indebtedness totaling EUR 1 158 million, USD 277 million, and CHF 62 million (see note 18). During 2022, EUR 115 million was paid back (2021: EUR 138 million, USD 277 million and CHF 62 million). As per 31 December 2022, certificates of indebtedness totaling EUR 543 million are recorded.
As per 31 December 2022, EUR 240 million was designated as a hedge of a net investment in some of Clariant’s European subsidiaries (2021: EUR 505 million).
The foreign exchange rate gain resulting from the hedge of net investments amounted to CHF 20 million for 2022 (2021: CHF 22 million) and is recorded in the cumulative translation difference in shareholders’ equity.
The hedge effectiveness is assessed at the beginning of the hedging relationship by way of recurring prospective effectiveness tests. Thus, it is ensured that there exists an economic relationship between the underlying transaction and the hedging instrument.
The Group enters into interest rate and cross-currency swaps that have identical critical terms as the hedged item, such as the reference rate, reset dates, payment dates, maturities, and notional amount. The Group does not hedge 100 % of its loans; therefore, the hedged item is identified as a proportion of the outstanding loans up to the notional amount of the swaps. As all critical terms matched during the year, the economic relationship was 100 % effective.
Hedge ineffectiveness for interest rate/cross-currency swaps is assessed using the following principles: The focus is on the credit value/debit value adjustment on the interest rate/cross-currency swaps that is not matched by the loan, as well as on differences in critical terms between the interest rate/cross-currency swaps and loans.
The cross-currency Basis Spread as per End of December 2022 was CHF -180 943 (2021: -100 748).
There was no ineffectiveness during 2022 and 2021 in relation to the interest rate/cross-currency swaps. Clariant has chosen the cost of hedging approach for the newly entered cash flow hedging relationship. The cross-currency basis spread is not part of the hedging relationship.
31. Employee participation plans
In 2019, the new Clariant Long-Term Incentive Plan (CLIP) was introduced with the first grants in April 2019. A subsequent grant took place in April 2020. The CLIP represents an equity-based award in the form of Performance Share Units with a three-year vesting period. The next review of the target achievements (vesting criteria) under this plan will be held in summer 2023, and vesting is scheduled to take place in September 2023. Target achievement reviews and vesting will continue on an annual basis for all subsequent grants.
For the first time in 2013, the Performance Share Unit (PSU) Plan was introduced for all senior managers with a three-year vesting period. The last grant under this plan took place in September 2018. Performance targets for this grant were met and granted PSUs vested in September 2021.
Under the Group Senior Management – Long-Term Incentive Plan (GSM-LTIP), a certain percentage of the actual bonus is granted to the plan participants in the form of registered shares of Clariant Ltd (investment shares). These shares vest immediately upon grant, but are subject to a three-year blocking period. Shares were granted for the first time in 2011, based on the performance achieved in the base year 2010. Similar plans were launched in all subsequent years. In the years 2013 to 2018, the plan participants also received an additional share free of cost (matching share) for each investment share held at the end of the blocking period. The number of shares not yet vested and thus disclosed are the matching shares already granted. No further grants were made after 2018 under this plan.
The expense recorded in the income statement and in equity spreads the costs of each grant over the measurement period and the vesting period. Assumptions are made concerning the forfeiture rate, which is adjusted during the vesting period so that at the end of the vesting period, there is only a charge for the vested number of shares.
In 2022, CHF 8 million was debited to the income statement for equity-settled share-based payments (2021: income of CHF 12 million).
As of 31 December 2022, the total carrying value of liabilities arising from equity-settled share-based payments, entirely recognized in equity, is CHF 21 million (2021: CHF 22 million).
SHARES FOR MEMBERS OF MANAGEMENT AND THE EXECUTIVE COMMITTEE/EXECUTIVE STEERING COMMITTEE
Base year | Granted | Vesting in | Fair value at grant date | Number 31.12.2022 | Number 31.12.2021 | |||||
---|---|---|---|---|---|---|---|---|---|---|
2018 | 2018 | 2021 | 23.58 | 542 | 4 665 | |||||
2019 | 2019 | 2022 | 15.91 | – | 785 275 | |||||
2020 | 2020 | 2023 | 12.87 | 823 423 | 1 025 099 | |||||
2021 | 2021 | 2024 | 19.20 | 3 891 | 3 891 | |||||
2021 | 2021 | 2024 | 18.84 | 20 317 | 20 317 | |||||
2021 | 2021 | 2024 | 18.34 | 1 000 | 1 000 | |||||
2021 | 2021 | 2024 | 13.64 | 904 728 | 1 154 066 | |||||
2022 | 2022 | 2025 | 16.07 | 3 500 | – | |||||
2022 | 2022 | 2025 | 17.63 | 14 862 | – | |||||
2022 | 2022 | 2025 | 17.79 | 51 220 | – | |||||
2022 | 2022 | 2025 | 14.02 | 723 170 | – | |||||
Total | 2 546 653 | 2 994 313 |
Weighted average exercise price | Shares 2022 | Weighted average exercise price | Shares 2021 | |||||
---|---|---|---|---|---|---|---|---|
Shares outstanding at 1 January | 14.03 | 2 994 313 | 18.82 | 2 395 698 | ||||
Granted | 878 944 | 1 234 206 | ||||||
Exercised / distributed | –265 178 | –349 886 | ||||||
Cancelled / forfeited | –1 061 426 | –285 705 | ||||||
Outstanding at 31 December | 13.66 | 2 546 653 | 14.03 | 2 994 313 | ||||
Fair value of shares outstanding in CHF | 34 794 843 | 42 010 204 |
The fair value of shares granted during 2022 is CHF 13 million (2021: CHF 16 million), calculated based on market value of shares at the grant date.
No options were granted in 2022 and 2021.
32. Personnel expenses
in CHF m | 2022 | 2021 | ||
---|---|---|---|---|
Wages and salaries | –766 | –819 | ||
Social welfare costs | –156 | –174 | ||
Shares and options granted to directors and employees | –8 | –12 | ||
Pension costs – defined-contribution plans | –18 | –22 | ||
Pension costs – defined-benefit plans | –38 | –39 | ||
Total personnel expenses | –986 | –1 066 | ||
thereof reported under discontinued operations | – | 133 | ||
Total continuing operations | –986 | –933 |
33. Related-party transactions
Clariant maintains business relationships with related parties. One group consists of the associates and joint ventures, of which the most important ones are described in note 8. The most important business with these companies is the purchase of services by Clariant (e.g., energy and rental of land and buildings) in Germany and the rendering of services to the Global Amines group.
The second group of related parties is key management, comprising the Board of Directors and the Executive Steering CommitteeExecutive Steering CommitteeThe Executive Steering Committee (ESC) is authorized by the Board of Directors to steer the company. It has overall strategic and financial responsibility, including for our profit and loss statement. The ESC consists of the Chief Executive Officer (CEO), the Chief Financial Officer (CFO), and the three Business Presidents.. The information required by the Ordinance against Excessive Compensation in Stock Exchange-Listed Companies regarding the emoluments for the members of the Board of Directors and the Executive CommitteeExecutive CommitteeUntil 30 June 2022, the Executive Committee was mainly responsible for implementing and monitoring the Group strategy, for the financial and operational management of the Group, and for the efficiency of the Group’s structure and organization. Effective 1 July 2022, the Executive Committee was replaced by the Executive Steering Committee (ESC)./Executive Steering CommitteeExecutive Steering CommitteeThe Executive Steering Committee (ESC) is authorized by the Board of Directors to steer the company. It has overall strategic and financial responsibility, including for our profit and loss statement. The ESC consists of the Chief Executive Officer (CEO), the Chief Financial Officer (CFO), and the three Business Presidents. is disclosed in the Compensation Report.
More information on the relationship with the Board of Directors is given in the Corporate Governance Report (non-audited).
The third group of related parties is the pension plans of major subsidiaries. Clariant provides services to its pension plans in Switzerland, the United Kingdom, and the United States. These services comprise mainly administrative and trustee services. The total costs in 2022 of these services is less than CHF 1 million (2021: CHF 1 million), of which approximately half is charged back to the pension plans. The number of full-time employees corresponding to these is approximately two (2021: approximately four).
The fourth group of related parties is all companies pertaining to the SABIC Group, which is a 31.5 % shareholder of Clariant (see note 17). The most important business done with these companies is the sale and purchase of chemical products.
Transactions with related parties
in CHF m | 2022 | 2021 | ||
---|---|---|---|---|
Income from the sale of goods to related parties | 101 | 51 | ||
thereof to joint ventures | 26 | 9 | ||
thereof to associates | 48 | 11 | ||
thereof to SABIC companies | 27 | 31 | ||
Income from the rendering of services to related parties | 67 | 54 | ||
thereof to joint ventures | 31 | 32 | ||
thereof to associates | 36 | 22 | ||
Expenses from the purchase of goods from related parties | –91 | –33 | ||
thereof from joint ventures | –50 | –19 | ||
thereof from associates | –36 | –14 | ||
thereof from SABIC companies | –5 | – | ||
Expenses from services rendered by related parties | –201 | –261 | ||
thereof by joint ventures | –30 | –24 | ||
thereof by associates | –171 | –237 | ||
Expense from the purchase of property, plant, and equipment from related parties | –5 | –5 | ||
thereof from associates | –5 | –5 | ||
Expense from lease contracts with related parties | –6 | –6 | ||
thereof with associates | –6 | –6 |
Payables and receivables with related parties
in CHF m | 31.12.2022 | 31.12.2021 | ||
---|---|---|---|---|
Receivables from related parties | 26 | 26 | ||
thereof from joint ventures | 6 | 12 | ||
thereof from associates | 18 | 7 | ||
thereof from SABIC companies | 2 | 7 | ||
Payables to related parties | 39 | 55 | ||
thereof to joint ventures | 8 | 7 | ||
thereof to associates | 30 | 48 | ||
thereof to SABIC companies | 1 | – | ||
Loans to related parties | – | 15 | ||
thereof to joint ventures | – | – | ||
thereof to associates | – | 15 | ||
Loans from related parties | 1 | 1 | ||
thereof from associates | 1 | 1 |
Transactions with Key Management
in CHF m | 2022 | 2021 | ||
---|---|---|---|---|
Salaries and other short-term benefits | 11 | 9 | ||
Post-employment benefits | 2 | 1 | ||
Share-based payments | 4 | 3 | ||
Total | 17 | 13 |
There are no outstanding loans by the Group to any members of the Board of Directors or Executive Steering CommitteeExecutive Steering CommitteeThe Executive Steering Committee (ESC) is authorized by the Board of Directors to steer the company. It has overall strategic and financial responsibility, including for our profit and loss statement. The ESC consists of the Chief Executive Officer (CEO), the Chief Financial Officer (CFO), and the three Business Presidents..
34. Commitments and contingencies
Guarantees. No guarantees on behalf of third parties were issued in 2022 and 2021.
Purchase commitments. In the regular course of business, Clariant enters into relationships with suppliers whereby the Group commits itself to purchase certain minimum quantities of materials in order to benefit from better pricing conditions. These commitments are not in excess of current market prices and reflect normal business operations.
Clariant is engaged in contracts to buy a minimum quantity of ethylene for the next nine years and other materials in 2022. This implies a total purchase commitment of about CHF 720 million (2021: CHF 925 million).
Contingencies. Clariant operates in countries where political, economic, social, legal, and regulatory developments can have an impact on the operational activities. The effects of such risks on the Company’s results, which arise during the normal course of business, are not foreseeable and are therefore not included in the accompanying financial statements.
In the ordinary course of business, Clariant is involved in lawsuits, claims, investigations, and proceedings, including product liability, intellectual property, commercial, environmental and health, and safety matters. Although the outcome of any legal proceedings cannot be predicted with certainty, Management is of the opinion that, apart from those cases where a provision has already been recognized, there are no such matters pending that would likely have any material adverse effect in relation to its business, financial position, or results of operations.
A Clariant subsidiary in the United States has been named along with many other defendants in lawsuits involving per- and polyfluoroalkyl substances (PFASs). Clariant is monitoring the development of these cases, which relate to a line of business divested in 2013, and is defending all litigation matters related to PFAS. The initial trial on one of the PFASs litigation matters may occur no earlier than early 2023. As of this point in time, Clariant cannot assess if these litigation matters will have a material impact on Clariant’s financial results.
Environmental risks. Clariant is exposed to environmental liabilities and risks relating to its past operations, principally with respect to remediation costs. Provisions for nonrecurring remediation costs are made when there is a legal or constructive obligation and the costs can be reliably estimated. IIt is difficult to estimate the future action required by Clariant, as well as the associated costs, to correct the environmental effects of prior disposal or release of chemical substances by Clariant or other parties pursuant to environmental laws and regulations. The material components of the environmental provisions consist of costs to fully clean and refurbish contaminated sites and to treat and contain contamination at sites where the environmental exposure is less severe.
35. Exchange rates of principal currencies
The rates used to translate the consolidated balance sheets (closing rate) are:
31.12.2022 | 31.12.2021 | |||
---|---|---|---|---|
1 USD | 0.92 | 0.91 | ||
1 EUR | 0.99 | 1.03 | ||
1 BRL | 0.18 | 0.16 | ||
1 CNY | 0.13 | 0.14 | ||
100 INR | 1.12 | 1.23 | ||
100 JPY | 0.70 | 0.79 |
The sales-weighted average exchange rates used to translate the consolidated income statements and consolidated statements of cash flows are:
2022 | 2021 | |||
---|---|---|---|---|
1 USD | 0.96 | 0.92 | ||
1 EUR | 1.01 | 1.08 | ||
1 BRL | 0.19 | 0.17 | ||
1 CNY | 0.14 | 0.14 | ||
100 INR | 1.22 | 1.24 | ||
100 JPY | 0.72 | 0.83 |
36. Important subsidiaries
Country | Company name | Currency | Share-/paid in capital (in thousands) | Participation in % | Holding/ Finance/ Service | Sales | Production | Research | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Argentina | Clariant (Argentina) SA, Buenos Aires | ARS | 54 605 | 100.0 | • | • | ||||||||||
Australia | Clariant (Australia) Pty Ltd, Notting Hill | AUD | 1 902 | 100.0 | • | • | ||||||||||
Brazil | Clariant S.A., São Paulo | BRL | 276 953 | 100.0 | • | • | • | • | ||||||||
Companhia Brasileira de Bentonita Ltda, Vitoria da Conquista | BRL | 17 470 | 100.0 | • | • | |||||||||||
Consórcio CCPN, Niteroi | BRL | 26 113 | 100.0 | • | • | |||||||||||
Beraca Ingredientes Naturais S.A. | BRL | 18 158 | 100.0 | • | • | • | ||||||||||
Canada | Clariant (Canada) Inc., Toronto | CAD | 10 415 | 100.0 | • | • | ||||||||||
Chile | Clariant (Chile) Ltda., Maipú-Santiago de Chile | CLP | 15 | 100.0 | • | • | • | |||||||||
China | Clariant (China) Ltd., Hong Kong | HKD | 414 788 | 100.0 | • | |||||||||||
Clariant Catalysts (Nanjing) Co., Ltd., Nanjing | CNY | 321 822 | 100.0 | |||||||||||||
Clariant Chemicals (China) Ltd., Shanghai | CNY | 210 014 | 100.0 | • | • | • | ||||||||||
Clariant Chemicals (Huizhou) Ltd., Daya Bay, Huizhou | CNY | 523 560 | 100.0 | • | • | • | • | |||||||||
Clariant China Holding Limited, Hong Kong | HKD | 67 251 | 100.0 | • | ||||||||||||
Clariant Huajin Catalysts (Panjin) Ltd., Panjin City | CNY | 69 511 | 60.0 | • | ||||||||||||
Clariant Redhill Bentonite (Liaoning) Ltd., Jianping | CNY | 124 365 | 100.0 | • | • | |||||||||||
Clariant Specialty Chemicals (Zhenjiang) Co., Ltd., Zhenjiang | CNY | 166 431 | 100.0 | • | • | |||||||||||
Clariant Bentonite (Jiangsu) Co., Ltd., Zhenjiang | CNY | 79 058 | 100.0 | • | • | |||||||||||
Clariant Chemicals Technology (Shanghai) Ltd., Shanghai | CNY | 170 286 | 100.0 | • | • | • | ||||||||||
Clariant Specialty Chemicals (Jiaxing) Co., Ltd., Jiangxing | CNY | 213 552 | 100.0 | • | • | |||||||||||
Colombia | Clariant Colombia S.A., Cota (Cundinamarca) | COP | 2 265 | 100.0 | • | • | ||||||||||
France | Clariant Production (France), Choisy le Roi | EUR | 6 273 | 100.0 | • | • | • | |||||||||
Clariant Services (France), Choisy le Roi | EUR | 21 200 | 100.0 | • | ||||||||||||
Germany | Clariant Vierte Chemie GmbH | EUR | 30 | 100.0 | • | |||||||||||
Clariant Produkte (Deutschland) GmbH, Frankfurt a.M. | EUR | 9 348 | 100.0 | • | • | • | • | |||||||||
Clariant Plastics & Coatings (Deutschland) GmbH | EUR | 149 | 100.0 | • | • | • | • | |||||||||
Clariant SE, Frankfurt a.M. | EUR | 916 | 100.0 | • | ||||||||||||
Clariant Verwaltungsgesellschaft mbH, Frankfurt a.M. | EUR | 2 560 | 100.0 | • | ||||||||||||
Great Britain | Clariant Distribution UK Limited, Yeadon, Leeds | GBP | 500 | 100.0 | • | |||||||||||
Clariant Oil Services UK Ltd, Yeadon, Leeds | GBP | 400 | 100.0 | • | • | • | ||||||||||
Clariant Production UK Ltd, Yeadon, Leeds | GBP | 500 | 100.0 | • | • | • | • | |||||||||
Clariant Services UK Ltd, Yeadon, Leeds | GBP | 500 | 100.0 | • | ||||||||||||
Greece | Süd-Chemie Hellas Monoprosopi EPE, Adamantas, Milos | EUR | 548 | 100.0 | • | • | ||||||||||
India | Clariant India Private Limited, Navi Mumbai | INR | 10 829 | 100.0 | • | • | • | • | ||||||||
Süd-Chemie India Pvt. Ltd., Ernakulam | INR | 9 623 | 50.0 | • | • | |||||||||||
Clariant IGL BioEthoxylates Private Limited | INR | 220 | 51.0 | • | • | |||||||||||
Indonesia | PT. Clariant Indonesia, Tangerang | IDR | 267 577 | 100.0 | • | • | • | |||||||||
PT. Clariant Kujang Süd-Chemie Catalysts, Cikampek | USD | 3 447 | 76.9 | • | • | |||||||||||
PT. Clariant Specialties Indonesia, Tangerang Banten | IDR | 4 803 | 100.0 | • | ||||||||||||
PT. Clariant AdsorbentsAdsorbentsUsually solid substances which are able to selectively accumulate certain substances from adjacent gaseous or liquid phases. Indonesia, Sukabumi | IDR | 12 375 | 100.0 | • | • | |||||||||||
Italy | Clariant Prodotti (Italia) S.p.A., Milano | EUR | 1 000 | 100.0 | • | • | • | • | ||||||||
Società Sarda di Bentonite S.r.l., Santa Giusta | EUR | 2 050 | 100.0 | • | • | |||||||||||
Japan | Clariant (Japan) K.K., Tokyo | JPY | 450 | 100.0 | • | • | • | |||||||||
Clariant Catalysts (Japan) K.K., Tokyo | JPY | 544 | 61.5 | • | • | • | • | |||||||||
Korea | Clariant (Korea) Ltd., Pohang, Pohang-Si | KRW | 6 361 | 100.0 | • | • | ||||||||||
Luxemburg | Clariant Finance (Luxembourg) S.A., Luxemburg | EUR | 82 030 | 100.0 | • | |||||||||||
Malaysia | Clariant Oil Services (Malaysia) Sdn Bhd, Petaling Jaya | MYR | 411 | 48.9 | • | |||||||||||
Clariant Specialty Chemical (M) Sdn Bhd, Kuala Lumpur | MYR | 3 300 | 100.0 | |||||||||||||
Mexico | Clariant (Mexico) S.A. de C.V., Ecatepec de Morelos | MXN | 22 219 | 100.0 | • | • | • | • | ||||||||
Morocco | Clariant (Maroc) S.A., Casablanca | MAD | 4 000 | 100.0 | • | |||||||||||
Norway | Clariant Oil Services Scandinavia AS, Bergen | NOK | 4 725 | 100.0 | • | |||||||||||
Pakistan | Clariant Pakistan (private) limited, Karachi | PKR | 50 000 | 100.0 | • | |||||||||||
Peru | Clariant (Perú) S.A., Lima | PEN | 20 454 | 100.0 | • | • | • | |||||||||
Poland | Clariant Poland Spolka z.o.o., Konstantynów Łódzki | PLN | 3 000 | 100.0 | • | • | ||||||||||
Clariant Services (Poland) SP. z o.o., Łódź | PLN | 10 000 | 100.0 | |||||||||||||
Qatar | Clariant Qatar W.L.L., Mesaieed | QAR | 30 000 | 65.0 | • | • | ||||||||||
Romania | Clariant Products Ro Srl, Bucarest | RON | 105 261 | 100.0 | • | • | ||||||||||
Singapore | Clariant (Singapore) Pte. Ltd., Singapore | SGD | 21 500 | 100.0 | • | • | • | |||||||||
Clariant South East Asia Pte. Ltd., Singapore | SGD | 1 560 | 100.0 | • | • | |||||||||||
South Africa | Clariant Sasol Catalysts Ltd., Chloorkop, Gauteng | ZAR | 1 417 | 80.0 | • | |||||||||||
Clariant Southern Africa (Pty) Ltd. Chloorkop, Gauteng | ZAR | 6 | 100.0 | • | • | • | ||||||||||
Spain | Clariant Ibérica Producción S.A., Sant Joan Despi | EUR | 6 023 | 100.0 | • | • | • | • | ||||||||
Sweden | Clariant Production Sweden AB, Mölndal | SEK | 500 | 100.0 | • | • | ||||||||||
Switzerland | Clariant Consulting AG, Muttenz | CHF | 200 | 100.0 | • | |||||||||||
Clariant Chemical Consulting AG, Muttenz | CHF | 100 | 100.0 | • | ||||||||||||
Clariant International AG, Muttenz | EUR | 101 648 | 100.0 | • | • | • | • | |||||||||
Clariant Oil Services AG, Muttenz | CHF | 300 | 100.0 | • | ||||||||||||
Clariant Reinsurance AG, Muttenz | CHF | 3 000 | 100.0 | |||||||||||||
Clariant Produkte (Schweiz) AG, Muttenz | CHF | 5 000 | 100.0 | • | ||||||||||||
Clariant Additives (Switzerland) AG, Muttenz | CHF | 5 000 | 100.0 | • | • | |||||||||||
Taiwan | Clariant Specialty Chemicals (Taiwan) Co., Ltd., Taipei | TWD | 36 000 | 100.0 | • | • | ||||||||||
Thailand | Clariant (Thailand) Ltd., Bangkok | THB | 250 000 | 100.0 | • | • | ||||||||||
Turkey | Clariant (Türkiye) A.S., Ataşehir/İstanbul | TRY | 17 538 | 100.0 | • | • | ||||||||||
UAE | Clariant (Gulf) FZE, Jebel Ali, Dubai | AED | 1 000 | 100.0 | • | |||||||||||
USA | Clariant Corporation, Charlotte, NC | USD | 749 500 | 100.0 | • | • | • | • | ||||||||
1 The participation in % reflects the captital and voting rights in %.
|